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function	 may	 be	 a	 consequence	 of	 altered	 posttranslational	 modification.	 It	 is	
known	 that	 cAMP-dependent	 protein	 kinase	 A	 (PKA)	 can	 phosphorylate	 LTCC	
resulting	 in	 increased	Ca2+	 current	 (ICa).	PKA-dependent	LTCC	phosphorylation	
has	been	shown	to	occur	upon	acute	pressure	overload	partly	compensating	for	
reduced	 Ca2+	 release	 from	 sarcoplasmic	 reticulum	 (SR).	 However,	 the	 mecha-





and	 arrhythmogenesis	 upon	 pressure	 overload.	 Here,	 a	 novel	 PKA	 redox-dead	
knock-in	mouse	line	was	used	harboring	a	RI	point	mutation	that	results	in	the	
exchange	 of	 cysteine	17	with	 serine	 (KI).	Oxidation	 of	 cysteine	17	with	 conse-
quent	intersubunit	disulfide	bridge,	RI-RI	dimer,	formation	is	inhibited.	The	later	
is	a	prerequisite	for	catalytic	subunit	release	and	phosphorylation	of	target	pro-
teins,	 i.e.	 oxidative	 activation	 of	 the	 kinase.	 At	 baseline,	 no	 alterations	 in	 Ca2+	
handling	 (FURA-2-loaded	 isolated	 cardiomyocytes)	 or	 contractile	 function	











tricular	arrhythmias	 (ECG	and	programmed	ventricular	 stimulation),	which	 re-
sults	in	significantly	reduced	survival	rates	upon	pressure	overload.	In	summary,	
oxidative	activation	of	PKA	appears	to	be	important	for	adaptation	of	the	heart	
during	 increased	afterload.	Thus,	 stimulation	of	oxidative	PKA	activation	 could	
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mediates	 electrical	 activation,	 ion	 channel	 gating,	 excitation–contraction	 (EC),	
gene	expression,	hypertrophy	and	apoptosis	of	cardiac	muscle.	Intracellular	Ca2+	
concentrations	 are	 carefully	 regulated	 being	 at	 ~100	 nM	 under	 resting	 condi-
tions	and	increasing	to	~1	μM	during	cardiac	contraction,	systole.		However,	lo-
calized	Ca2+	 concentrations	are	even	higher	 inside	 the	 cardiomyocytes	and	can	
be	reached	up	to	~100	μM	during	systole	(Maier	and	Bers,	2002),	(Bers	and	Guo,	
2005).	It	is	known	that	many	factors	can	influence	this	highly	regulated	Ca2+	ho-




notypes,	 collectively	 known	 as	 cardiovascular	 diseases	 (CVDs).	 CVDs	 are	 the	
number	one	cause	of	death	globally:	more	people	die	annually	 from	CVDs	than	
from	 any	 other	 reasons	 (World	 health	 organization,	 WHO).	 Among	 the	 CVDs,	
heart	attack	and	stroke	are	usually	acute	events,	which	are	mainly	caused	by	a	
blockage	 that	prevents	blood	 from	 flowing	 to	 the	heart	 or	brain.	However,	 the	
ultimate	 consequence	 of	 these	 diseases	 is	 heart	 failure,	 which	means	 that	 the	
heart	 is	unable	 to	provide	sufficient	cardiac	output	 to	supply	the	metabolic	de-
mands	 of	 the	 organism.	 An	 estimated	 17.5	 million	 people	 died	 from	 CVDs	 in	
2012,	 representing	31%	of	 all	 global	 deaths.	Of	 these	deaths,	 an	 estimated	7.4	
million	were	due	 to	coronary	heart	disease	and	6.7	million	were	due	 to	stroke	
(WHO).	Until	now,	 two	fatal	pathways	were	reported	to	be	responsible	 for	 this	
high	mortality:	1)	progressive	decline	in	cardiac	contractile	function	(pump	fail-
ure)	and	2)	sudden	cardiac	death	due	to	arrhythmias.	The	contraction	abnormal-
ities	 start	 at	 the	 cardiomyocyte	 and	 trabecular	 level,	 whereas	 arrhythmia	 can	
happen	due	to	both	Ca2+	handling	and	cellular	 ionic	currents	(Bers,	2001).	 It	 is	
























(SR),	 named	 cardiac	 ryanodine	 receptors	 (RyR2).	 The	 Ca2+-influx-induced	 SR	
Ca2+	 release	 (CICR)	 rapidly	 increases	 the	 cytosolic	 Ca2+	 concentration	 to	 shape	
the	Ca2+	transient,	which	is	an	increase	in	cytosolic	free	Ca2+	from	about	100	nM	
to	about	1	µM	(Bers,	2002).	The	Ca2+	transient	then	activates	the	myofilaments,	






tion	of	 the	membrane	potential.	 Simultaneous	 time-dependent	 closure	of	LTCC	






Figure	 1.1.	 Schematic	 diagram	 of	 cardiac	 excitation-contraction	 coupling.	Ca2+	 ions	 enter	
through	the	L-type	calcium	channel	into	the	cardiomyocytes	and	exits	via	sarcoplasmic	reticulum	
Ca2+-ATPase	 (SERCA2a)	 and	 Na+/Ca2+-exchanger	 (NCX).	 Calcium	 entry	mediates	more	 Ca2+	 re-
lease	 from	SR	 via	RyR2	 receptors.	Na+	 ions	 enter	 through	 voltage-gated	Na+	 channel	 and	NCX,	
while	exits	via	Na+-K+	ATPase	 in	exchange	 for	K+.	Excess	K+	 then	exits	 the	 cell	 via	K+	 channels.	
(modified	from	Wagner	et	al.,	2013)	
	
the	 SR	 Ca2+-ATPase	 (SERCA2a)	 into	 the	 SR,	whereas	 smaller	 fraction	 exported	
into	the	extracellular	space	by	the	sarcolemmal	Na+/Ca2+-exchanger	(NCX)	(Bers,	
2002,	 (Bers,	 2008;	 Fill	 and	Copello,	 2002).	During	 steady-state,	 Ca2+	 fluxes	 are	
balanced	(Bers	et	al.,	2003).	Thus,	the	same	amount	of	Ca2+	that	entered	the	cell	



































times	 per	minute.	 To	maintain	 this	 Ca2+	 cycle	 ion	 channels,	 pumps,	 and	 other	
proteins	are	specially	organized	on	 the	membrane.	For	example,	 the	density	of	
LTCC	is	much	higher	in	T-tubules	compared	to	surface	sarcolemma	to	continue	
this	 Ca2+	 cycle.	 In	 cardiac	muscle,	 these	 junctions	 are	more	 apparent	 as	 dyads	
and	can	occur	either	at	the	surface	sarcolemma	or	with	the	T-tubular	membrane.	
RyR2	 are	 organized	 in	 a	 distinct	 pattern	 on	 the	 SR,	 underneath	 the	 T-tubular	










vation	of	LTCC	 in	all	 junctions,	 to	produce	a	relatively	homogenous	 increase	 in	















Ventricular	 hypertrophy	 occurs	 in	 response	 to	 numerous	 physiological	 and	
Introduction	
	 6	
pathophysiological	 stimuli.	 In	 physiological	 settings,	 this	 can	 be	 considered	 as	
compensatory	hypertrophy,	where	 it	 increases	cardiac	 function	and	stroke	vol-
ume	 (and	 lower	 resting	 heart	 rate).	 In	 contrast,	 pathophysiological	 stimuli	 in-
clude	hemodynamic	 load	 (pressure	 or	 volume)	 and	neurohumoral	 stimuli	 (e.g.	























arrhythmogenic.	 For	 example,	 immediately	 after	 initial	 repolarization	 phase	 of	
the	action	potential,	early	afterdepolarizations	(EAD)	may	occur	due	to	increased	
late	Na+	current	(late	INa),	This	can	consequentially	prolong	action	potential	(AP)	
duration	 (Sossalla	 et	 al.,	 2011;	 Wagner	 et	 al.,	 2015)	 (Wagner	 et	 al.,	
2011)	(Hashambhoy	 et	 al.,	 2011).	 This	 long	 AP	 can	 inhibit	 ICa	 during	 cytosolic	





the	 voltage	 of	 the	 action	 potential	 plateau,	 which	 slows	 repolarizing	 currents	
and,	at	 the	 same	 time,	 reactivates	depolarizing	Ca2+	currents	via	LTCC	(Zhao	et	
al.,	 2012).	 In	 addition,	Ca2+	 channel	 activation	at	more	negative	membrane	po-









SR	Ca2+	 raises	 the	sensitivity	of	RyR2	 to	cytosolic	Ca2+	 (Tripathy	and	Meissner,	
1996;	Xu	et	al.,	1998a;	Xu	et	al.,	1998b).	Moreover,	hyper-phosphorylated	or	oxi-
dized	RyR2	can	also	facilitate	the	Ca2+	release	process	(Belevych	et	al.,	2012)	(Sag	
et	 al.,	 2009).	This	 elevated	 cytosolic	Ca2+	 can	activate	 transient	 inward	current	
mediated	depolarization	of	 the	membrane	and	after	 contraction.	Both	of	 these,	





ty,	which	 is	 increased	due	 to	diastolic	Ca2+	overload,	ultimately	 leads	 to	a	 local	
depolarization	and	electrical	 instability.	Like	RyR2,	modifications	of	NCX	via	ei-
ther	oxidation	or	kinase-mediated	phosphorylation	(which	can	also	undergo	ox-



















mainly	 responsible	 for	 this	 phenotype.	 These	 force	 changes	 are	 paralleled	 to	
changes	in	Ca2+	transient	amplitudes	and	slowing	of	the	rate	of	relaxation	(Bers,	
2001).	Feldman	et	al.	showed	data	suggesting	that	down-regulation	of	SERCA2a	
expression	might	mark	 the	 transition	 from	hypertrophy	 to	HF	 (Feldman	 et	 al.,	
1993).	 In	HF,	 reduction	 in	 thyroid	 hormone	 results	 in	 decreased	 SERCA2a	 but	














changer	(Dipla	et	al.,	1999).	However,	 this	 is	only	true	at	 low	heart	rates	when	
AP	duration	 is	unusually	prolonged.	This	may	also	explain	why	the	Ca2+	 transi-




















2001).	 In	 human	 HF,	 ventricular	 tachycardia	 (VT)	 is	 mostly	 initiated	 by	 non-
reentrant	 mechanisms,	 like	 EADs	 or	 DADs,	 which	 is	 true	 for	 100%	 of	 VT	 in	
nonischemic	HF	and	50%	in	post-ischemic	HF	(Pogwizd	et	al.,	1992;	Pogwizd	et	
al.,	1998).	In	heart	failure,	 low	heart	rates	increased	the	probability	that	ICa	has	


















































physiological	 frequencies,	AP	duration	 is	not	 always	 so	prolonged	 in	HF.	Addi-
tionally,	DADs	are	 also	 reported	 in	HF.	The	key	 facets	of	HF	 that	 contribute	 to	
DAD-induced	triggered	arrhythmias	are:	1)	 increased	Na+/Ca2+	exchanger	func-
tion,	2)	reduced	inward	rectifier	current,	IK1	and	3)	residual	β-AR	activity	(to	suf-











cells	 at	 1985	 and	 who	 divided	 them	 into	 three	 groups.	 L-type	 Ca2+	 channels	
(LTCC),	which	have	a	 large	conductance	(~25	pS	 in	110	mM	Ba2+),	 long	 lasting	






However,	 these	 groupings	 are	 very	 superficial,	 and	 there	 are	 large	 differences	
among	L-type	channels.	For	example,	ω-conotoxin	can	strongly	inhibit	neuronal	
L-type	Ca2+	channels,	but	not	cardiac	or	skeletal	muscle	L-type	channels.	Besides,	









nels.	 ICa,L	 is	ubiquitous	 in	cardiac	myocytes,	whereas	cardiac	 ICa,T	has	 localized	
distribution,	 like	 in	atrial	cells.	 It	has	been	reported	that	T-type	current	 is	typi-
cally	small	or	absent	in	ventricular	cardiomyocytes	but	may	be	more	prominent	







































helices	are	depicted	as	 cylinders;	 the	 lengths	of	 lines	 correlate	approximately	 to	 the	 lengths	of	
the	 polypeptide	 segments.	 Pore-forming	 α1C	 subunit	 illustrated	 as	 four	 homologous	 repeated	
domains	 (I–IV),	 each	 composed	 of	 six	 transmembrane	 segments.	 The	 cytoplasmic	 β	 subunit	 is	
formed	 by	 two	 highly	 conserved	 domains,	 and	 the	 amino-terminal	 portion	 of	 the	 second	 con-






















































cytoplasmic	 loop	 in	 channel	 inactivation	 (Bers,	2001).	The	apparent	 lack	of	 in-





(Zhang	 et	 al.,	 1994),	 Stotz	 and	 Zamponi	 (Stotz	 and	 Zamponi,	 2001)	 suggested	
that	all	four	S6	segments	of	the	calcium	channel	α1	subunit	contribute	to	inacti-













inactivated,	 resulting	 in	a	current	 that	rises	 to	a	peak	value	 from	which	 it	 then	
decays.	The	overlapping	of	activation	and	 inactivation	of	Ca2+	 channel	 currents	
implied	 the	 existence	of	 a	 steady	 state.	 This	 region	of	 overlap	 is	 called	 as	Ca2+	
"window"	 current	 that	 exists	 near	 action	 potential	 plateau	 voltages	 (fig.1.4)	
(Brown	et	al.,	1984;	Cohen	and	Lederer,	1987;	Josephson	et	al.,	1984;	Reuter	and	
Scholz,	1977).	Within	this	window,	it	is	postulated	that	channel	transitions	may	






Interestingly,	 L-type	 Ca2+	 window	 current	 has	 been	 proposed	 to	 be	 pro-










tion	 and	 availability.	 ICa	 availability	 is	
measured	by	depolarizing	from	–90	mV	to	
the	 indicated	Em	 for	1	 sec	 and	 then	 test-
ing	 the	 remaining	 available	 ICa	 at	 Em	 =0	
mV	([Ca]o=1	mM).	The	result	is	referred	to	
as	 a	 steady	 state	 inactivation	 curve.	 Acti-
vation	 is	 measured	 by	 dividing	 the	 peak	
current	 by	 the	 apparent	 driving	 force	
(Em–Erev)	 according	 to	 Ohm's	 law	
(G=I/∆V).	Both	curves	are	described	by	a	
Boltzmann	 relation.	 Black	 curves	 are	 for	
healthy	 and	 red	 curves	 indicating	 	 dis-
eased	 condition	 (arbitrary	 data;	 Em:	




Regulation	of	 calcium	channel:	Voltage-gated	Ca2+	 channels	 are	 responsible	 for	
translating	action	potential	mediated	electrical	signal	into	the	intracellular	Ca2+-
mediated	signal	(see	above).	Interestingly,	LTCC	can	be	regulated	in	its	periphery	
because	 it	 forms	 large	macromolecular	 complexes	 with	 several	 kinases,	 phos-
phatases,	 proteases	 and	 other	 proteins	 in	 the	 plasma	 membrane.	 It	 has	 been	
shown	 that	CaMKII-mediated	phosphorylation	of	β2A-subunit	 at	T498	 resulting	
in	increased	ICa	(Grueter	et	al.,	2006).	Moreover,	PKA	is	known	to	phosphorylate	





































phate	 (ATP)	 into	 cyclic	3,5-monophosphate	 (cAMP)	 that	 in	 turn	activates	 the	 cAMP-dependent	
protein	kinase	(PKA)	to	phosphorylate	α1C	(CaV1.2)	of	LTCC.	
	
In	 addition	 to	Em	 shift,	 β-stimulation	may	 increase	 ICa	 by	making	 the	 coupling	
between	the	charge	movement	and	opening	of	 the	Ca2+	channels	more	efficient	
(Bers,	2001).	However,	 in	contrast	to	phosphorylation,	 the	α1C-subunit	has	also	













































with	 PKA,	 CaMKII,	 protein	 phosphatases	 1	 and	 2A,	 Calmodulin,	 and	 FKBP12.6	
(Fill	and	Copello,	2002).	RyR2	is	closely	 localized	with	the	LTCC	in	the	t-tubule	
region,	 to	 maintain	 the	 Ca2+-induced	 Ca2+	 release	 (CICR)	 of	 EC	 coupling.	 This	
CICR	 initiated	when	Ca2+	enter	 to	 the	cell	 through	LTCC,	which	 in	 turn	 induces	
Ca2+	release	from	the	SR	via	RyR2,	 leading	to	a	substantial	 increase	in	cytosolic	
Ca2+	concentration.	As	a	consequence	systolic	Ca2+	transient	amplitude	increases	
which	 ultimately	 activates	 the	 contractile	 system	 and	 generates	 the	 force	 for	
contraction.		
Post-translational	 modifications	 of	 RyR2,	 via	 phosphorylation	 by	 CaMKII	 (at	
Ser2814/2815)	and	PKA	(at	Ser2808/2809),	can	mediate	its	activation.	Recently	
it	has	been	reported	that	kinases,	which	can	modulate	RyR2	function,	can	be	oxi-




can	 also	 be	modulated	 by	 redox-regulation.	 In	 the	 presence	 of	 oxidants,	 RyR2	
monomer	can	form	either	disulfide	bonds	between	any	of	its	21	free	cysteines	or	
other	oxidized	derivatives	 like	 S-nitrosylated	products	 (Abramson	and	Salama,	
1989)	(Xu	et	al.,	1998a)	(Liu	et	al.,	1994).	It	has	been	reported	that	at	least	8	thi-
ols	 per	 subunit	 need	 to	 be	 oxidized	 to	mediate	 SR	 calcium	 release	 (Abramson	





these	 oxidative	 events	 are	 further	 explained	 by	 other	 groups	where	 they	 have	
shown	that	oxidants	(like	2,2′-dithiodipyridine,	DTDP,	H2O2	or	glutathione	dep-
rivation)	 can	 increase	RyR2	 open	 probability	 (Po),	which	 is	 responsible	 for	 in-

















with	which	 it	contracts,	 thereby	changing	 its	output.	Contraction	of	heart	 is	 in-
























Upon	binding	appropriate	 ligand	 to	 the	 receptor,	 the	 receptor	has	a	 conforma-
tional	change	and	allows	the	Gα	subunit	to	be	dissociated	from	Gβγ	using	the	en-
ergy	 from	GTP.	Both	Gαs-GTP	 and	Gβγ	 can	 then	 activate	 different	 signaling	 cas-
cades	 (or	 second	 messenger	 pathways)	 and	 effector	 proteins	 (Khafizov	 et	 al.,	
2009;	Sprang	et	al.,	2007).	In	the	case	of	β-adrenergic	receptor,	after	dissociation	
Gαs-GTP	moves	 to	membrane	bound	adenylyl	 cyclase	 (AC).	Using	 the	energy	of	
ATP,	this	activated	AC	then	produces	cAMP,	which	then	acts	as	a	second	messen-
ger	inside	the	cell.		The	Gα	subunit	will	eventually	hydrolyze	the	attached	GTP	to	




effectors	 of	 the	 β-receptors,	 which	 can	 be	 activated	 by	 cAMP.	 PKA	 is	 a	 homo-









the	 heart	 (Desseyn	 et	 al.,	 2000).	 However,	 each	 catalytic	 subunit	 consists	 of	 a	
small	and	a	large	lobe	along	with	the	active	site,	which	forms	a	cleft	between	the	
two	lobes.	The	small	lobe	provides	the	binding	site	for	adenosine	5-triphosphate	
(ATP),	 and	 the	 large	 lobe	 provides	 a	 docking	 surface	 for	 peptide/protein	 sub-




ly	 impacting	on	kcat	 (measures	 the	number	of	 substrate	molecules	 turned	over	
per	enzyme	molecule	per	second)	(Steichen	et	al.,	2010).		
		
Figure	 1.6.	Model	 of	 PKA	 RIα	 tetrameric	 holoenzyme.	 Proposed	positions	of	 two	PKA	RI:C	
dimers	 correspond	 to	 the	 observed	packing.	 Possible	position	of	 the	dimerization/docking	do-






N-terminal	 dimerization	 and	 docking	 domain	 (D/D)	 to	 the	 two	 3’,	 5’-	 cyclic	
adenosine	monophosphate	 (cAMP)	 binding	 domains	 (Taylor	 et	 al.,	 1990).	 The	
D/D	domain	at	the	N-terminal	of	the	R	subunits	provides	the	interface	for	R	sub-
unit	 homo-dimerization,	 and	 is	 also	 the	 point	 of	 contact	 between	 PKA	 and	 A-
kinase	anchoring	proteins	(AKAPs),	scaffold	proteins	that	tether	PKA	to	specific	








tive	state,	RI	and	 II	 tether	 to	catalytic	 subunit	 through	 inhibitory	domains	pre-
sented	either	as	a	pseudo-substrate	site	 in	RI	(Poteet-Smith	et	al.,	1997)	or	the	
phosphorylatable	Ser96	in	RII	(Carmichael	et	al.,	1982).	Upon	β-adrenergic	stim-










appears	 to	 be	 primarily	 targeted	 to	 A-kinase	 anchoring	 proteins	 (AKAPs)	 that	
are	localized	to	distinct	subcellular	compartments	(Corbin	et	al.,	1977;	Scholten	
et	 al.,	 2007).	 There	 are	 significant	 uncertainties	 about	 target	 specificity	 of	 the	
PKA	subtypes.	For	example,	Burton	et	al.	reported	that	PKA	RII,	which	interacts	

















a	 compensation	of	RII	 beta	KO,	 shows	more	 avidity	 and	 affinity	 to	 cAMP	 com-













tial	 requirement	was	 further	proven	by	 the	knockout	of	RIα	 in	mice,	which	 re-
sults	 in	 early	 embryonic	 lethality	 due	 to	 aberrant	 cardiac	 morphogenesis	
































Role	 of	 PKA	 in	 physiologic	 conditions:	 Phosphorylation	 of	 LTCC	 and	 RyR2	 in-
creases	ICa	and	CICR	resulting	in	increased	Ca2+	transient	amplitude	and	contrac-
tile	 force	 (positive	 inotropic	effect).	 It	has	been	 found	 that	β-AR	mediated	PKA	
phosphorylation	 increases	 ICa	 amplitude	 and	 shifts	 activation	 to	more	negative	
Em.	Furthermore,	current	also	 inactivates	quickly	(owing	to	greater	Ca2+	reflux	
and	 release).	 Thus	 there	 is	 only	 a	 little	 increase	 in	 ICa	 during	 action	 potential	
(Bers,	2008).	Moreover,	it	has	been	found	that	ICa	density	is	unchanged	in	canine	
tachycardia-induced	heart	failure	model.	This	unaltered	ICa	is	may	be	due	to	un-





Moreover,	 PKA-dependent	 PLB	 phosphorylation	 results	 in	 increased	 SERCA2a	
activity.	The	latter	could	increase	SR	Ca2+	content	and	make	more	Ca2+	available	
for	the	consecutive	CICR	(positive	inotropic	effect).	It	also	enhances	the	speed	of	
Ca2+	 removal	 thus	 stimulating	 relaxation	 (positive	 lusitropic	 effect).	Moreover,	
PKA-dependent	phosphorylation	of	 troponin	 I	 reduces	myofilament	Ca2+	 sensi-
tivity,	which	 further	 contributes	 to	 faster	 relaxation	 (positive	 lusitropic	 effect).	
(Ramirez-Correa	et	al.,	2010)	 (Schulman	and	Greengard,	1978;	Schworer	et	al.,	
1986).	 Another	 target	 of	 PKA	 is	 Nav1.5,	 which	 is	 phosphorylated	 at	 S526	 and	
S529	(Murphy	et	al.,	1996).	In	consequence	of	phosphorylation,	Nav1.5	traffick-
ing	to	the	sarcolemma	is	enhanced	resulting	in	increased	peak	INa	amplitude.	The	
larger	peak	 INa	 improves	ventricular	 conduction	velocity	by	 faster	AP	upstroke	











found	 in	heart	 failure)	 leads	 to	down-regulation	of	β-AR	signaling	due	 to	nega-
tive	feedback	to	this	pathway	(Bunemann	et	al.,	1999;	Lefkowitz,	1998;	Summers	
et	al.,	1997)	(Bohm	and	Lohse,	1994;	Ungerer	et	al.,	1993).	Wang	et	al.	believed	
that	 there	 is	 a	 time-dependent	 switch	 from	 the	 PKA-dominant	 pathway	 to	 the	
CaMKII-dominant	 pathway	 after	 receptor	 stimulation,	where	 the	 sustained	 re-
sponses	were	largely	PKA-	independent,	and	were	sensitive	to	CaMKII	(Wang	et	






tubules	with	a	massive	 redistribution	of	β-receptors	 in	 rat	heart	 failure	model.	
According	 to	 their	 report,	during	heart	 failure	β1	receptors	keep	staying	on	 the	
cell	surface,	whereas	β2-AR	rearranged	from	the	T-tubules	to	the	cell	crest	in	fail-
ing	 cardiomyocytes	 and	 loss	 proper	 PKA	 localization	 (Nikolaev	 et	 al.,	 2010).	
Moreover,	they	have	reported	that	in	β2-ARs	in	detubulated	areas	of	failing	car-




Therefore,	 it	 can	be	summarized	 that	a	paradoxical	 reduction	of	PKA-mediated	
signaling	may	happen	during	heart	failure,	despite	the	fact	that	β-AR	agonists	are	
present	in	large	amounts	in	the	blood	and	extracellular	space.	The	inability	of	the	




has	 been	 reported,	 which	 is	 independent	 of	 beta-adrenergic	 stimulation	 and	
cAMP	levels	(Brennan	et	al.,	2006).	Oxidation	of	C17	and	C38	of	the	RI	homodi-
mer	 could	 lead	 to	 intermolecular	 RI-RI	 disulfide	 bond	 formation,	 where	 C17	
from	one	subunit	makes	an	anti-parallel	bridge	to	C38	of	another	subunit.	Upon	






Figure	 1.8.	 Schematic	 diagram	
showing	 activation	 pathways	 of	




to	 the	 regulatory	 subunits,	 confor-
mational	 changes	 happen,	 which	
releases	 the	 catalytic	 subunits.	
Even	in	the	absence	of	cAMP,	a	sim-
ilar	phenomenon	is	observed	upon	









undergo	 oxidant-dependent	 activation,	 suffered	 from	 impaired	 angiogenesis	 in	
models	of	hind-limb	ischemia	and	tumor	vascularization	(Burgoyne	et	al.,	2015).		
However,	the	role	of	oxidant-dependent	PKA	activation	in	the	heart,	specifically	





the	 Ca2+/Calmodulin	 kinase	 (CaMKII).	 CaMKII	 can	 be	 activated	 by	 a	 PKA-
dependent	increase	in	Ca2+,	or	a	PKA-independent	manner	via	a	guanine	nucleo-
tide	 exchange	 protein	 directly	 activated	 by	 cAMP	 (Epac)	 (Grimm	 and	 Brown,	





Ca2+-bound	 Calmodulin	 (Ca2+-CaM)	 to	 its	 regulatory	 domain.	 Resulting	 confor-



















ulum	Ca2+-ATPase	 (SERCA2a)	 at	 S38	 (Toyofuku	 et	 al.,	 1994)	 and	 its	 regulator,	
Phospholamban	 (PLB)	 at	T17	 (Le	Peuch	et	 al.,	 1979;	 Simmerman	et	 al.,	 1986),	
ryanodine	 receptor	 (RyR2)	 at	 S2814/2415	 (Wehrens	 et	 al.,	 2004)	 and	 sarco-
lemmal	 L-type	 Ca2+	 channels	 (LTCC)	 (Grueter	 et	 al.,	 2006;	 Koval	 et	 al.,	 2010).	
Phosphorylation	 of	 Nav1.5	 (Wagner,	 Dybkova	 et	 al.	 2006,	 Hund,	 Koval	 et	 al.	
2010)	and	RyR2	causes	increased	Na+	entry	as	well	as	SR	Ca2+	depletion	leading	
to	Na+	and	Ca2+	overload	(Ai	et	al.,	2005;	Maier	et	al.,	2003;	Wagner	et	al.,	2011;	




In	 addition	 to	 substrate	 phosphorylation,	 CaMKII	 auto-phosphorylates	 itself	 at	
T286/T287,	depending	on	species,	which	prevents	re-association	of	catalytic	and	





nit	 cannot	 re-associate	with	 the	 regulatory	domain	 thus	 can	 continue	 its	 enzy-
matic	activity.		
It	has	been	reported	that	 treatment	of	cardiomyocytes	with	H2O2	 increases	 the	
incidence	 of	 pro-arrhythmogenic	 Ca2+	 sparks	 and	 pro-hypertrophic	 Ca2+	 over-
load	downstream	of	CaMKII	activation	(Wagner	et	al.,	2011).	In	addition,	AngII-
dependent	 activation	of	NOX2,	 in	vitro	 and	 in	vivo,	 increased	M281/282	oxida-
tion	and	induced	apoptosis,	which	was	lost	in	M281/282V	CaMKII	knock-in	(KI)	
mice	 (Erickson	 et	 al.,	 2008).	 Interestingly,	Methionine	 sulfoxide	 reductase	A,	 a	






can	 control	 EC	 coupling	 at	 several	 stages.	 The	 activation	 mechanism	 varies	
among	the	subtypes.	For	example,	isoform	α,	βI,	βII,	and	γ	are	activated	by	Ca2+	
and	diacylglycerol	(DAG);	in	contrast,	δ,	ɛ,	θ,	η,	ζ	and	λ	are	activated	by	distinct	
lipids	 (Dorn	 and	 Force,	 2005).	Moreover,	 a	 report	 has	 shown	duel	 role	 of	 oxi-
dants	 on	 PKC,	 where	 mild	 oxidation	 can	 reduce	 Ca2+/phospholipid-dependent	
activation	 followed	by	an	 immediate	 activation,	 independent	of	Ca2+	 and	phos-
pholipids	(Gopalakrishna	and	Anderson,	1989).	Upon	excessive	oxidant	produc-
tion,	these	intermediate	effects	diminished	and	the	enzyme	completely	inactivat-







Oxidants	 are	 reactive	 molecules;	 produced	 under	 different	 physiological	 and	
pathophysiological	settings.	These	are	mainly	reactive	molecules	containing	oxy-
gen	 (reactive	oxygen	species,	ROS)	 in	either	 their	 radical	or	non-radical	 forms.	
These	oxidants	are	unstable	molecules	and	can	attack	any	biological	molecules	
including	 protein	 (ex.	 fragmentation	 or	 aggregation),	 lipid	 (ex.	 lipid	 peroxida-
tion)	and	DNA	(destruction	of	sugar	or	base,	strand	breakage)	(Pham-Huy	et	al.,	
2008).	Oxidants	 can	be	generated	enzymatically	or	by	electrons	 that	 leak	 from	





H2O2	 via	 the	 Fenton	 reaction,	 where	 Fe2+	donates	 an	 electron	 to	 become	 Fe3+,	















(vitamin	 E	 associated	 membrane	 damage)	 both	 are	 detrimental	 for	 the	 body	
(Maxwell,	 1995)	 (Bjelakovic	 et	 al.,	 2007;	 Griendling	 and	 FitzGerald,	 2003;	
Hennekens	 et	 al.,	 1996;	Melov,	 2002).	 The	underlying	mechanism	may	 involve	
electron	 transfer	 reaction	 between	 free	 radicals	 and	 target	 molecules.	 During	
this	transfer,	the	unpaired	highly	reactive	electron	of	the	free	radical	collects	one	

















cal	 is	scavenged,	and	no	 further	oxidation	reaction	 is	possible.	The	 latter	 is	 the	
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case	 for	 reaction	 of	 oxidants	 with	 physiologic	 antioxidant	 concentration	
(Maxwell,	1995).		
	
Interestingly,	 the	 role	 of	 oxidants	 in	 cellular	 signaling	 is	 further	 evident	 from	
H2O2.	H2O2	 is	produced	from	the	highly	reactive	oxidant	superoxide	(O2*-)	via	a	
reaction	catalyzed	by	superoxide	dismutase	(SOD).	However,	due	to	its	high	re-
activity	O2*-	 has	 very	 limited	 diffusion	 distance,	 in	 the	 range	 of	 only	 a	 few	 na-
nometers,	and	scavenged	rapidly.	H2O2,	on	the	other	hand,	is	less	reactive,	small,	
and	neutral.	Besides,	it	is	highly	diffusible	and	able	to	cross	cellular	membranes	
to	 act	 as	 a	 signaling	 molecule.	 Thus,	 H2O2	 can	 execute	 multiple	 physiological	
roles	within	 the	 cell	 (Burgoyne	et	 al.,	 2012;	Wagner	et	 al.,	 2013).	On	 the	other	









cular	 tone,	 but	 also	 in	 the	 stress	 responses	 to	hypoxia,	 ischemia,	 inflammation	




There	are	 several	 sources	 for	oxidants	within	 the	cell.	Among	 them,	mitochon-
dria	are	 the	primary	source	of	cellular	ROS.	Under	normal	circumstances,	O2	 is	













lecular	oxygen	 to	generate	O2*-	and/or	H2O2.	Nitric	Oxide	synthases	 (NOS)	generate	 *NO	and	L-
citrulline	 from	arginine	and	O2.	 In	 the	absence	of	 tetrahydrobiopterin	 (BH4)	or	L-arginine,	un-
coupled	NOS	enzymes	resulting	 in	the	production	of	O2*-	rather	than	*NO.	 In	addition,	activated	











sheep.	 This	 is	 a	 four	 amino	 acid	 synthetic	 peptide	 (phenylalanine-d-arginine-
phenylalanine-lysine),	 selectively	 reaches	 the	 inner	 mitochondrial	 membrane,	
scavenges	 ROS	 through	 a	 dimethyltyrosine	 group	 and	 reduces	 mitochondrial	
ROS	production	(Cho	et	al.,	2007;	Dai	et	al.,	2013;	Kloner	et	al.,	2012).	Moreover,	








































































trons	 from	NADPH	 to	 flavin	 and	 ultimately	 to	molecular	 O2	 (2O2	 +	 NADPH	à	
2O2*-	+	H+	+	NADP+)	(Burgoyne	et	al.,	2012).	The	NOX	is	a	multi-subunit	enzyme	
complex	 composed	of	membrane	 spanning	 flavocytochrome	b558	 (consisting	 of	
flavin,	 the	 haem-binding	 gp91phox,	 and	 p22phox),	 the	 cytosolic	 regulators	








NOX5	 only	 found	 in	 higher	mammals).	Within	 the	 cardiovascular	 system,	 both	
NOX2	and	NOX4	are	expressed	in	endothelium	and	cardiomyocytes.	NOX2	is	lo-
cated	 predominantly	 on	 the	 plasma	 membrane	 and	 activated	 by	 hormones,	







Compared	 to	 other	 NOX	 enzymes,	 which	 mainly	 produced	 superoxide	 (O2*-),	
NOX4	 can	 produce	H2O2	with	 its	 special	 E-loop	 structure,	which	 differs	 signifi-
cantly	 from	 that	 of	NOX2.	 E-loop	 contains	 a	 highly	 conserved	 histidine	moiety	
that	 may	 hinder	 superoxide	 egress	 and	 provide	 a	 source	 of	 protons,	 allowing	
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dismutation	 to	 form	H2O2	 (Takac	et	al.,	2011).	This	may	 imply	distinct	 roles	of	
NOX	isozymes	inside	the	cell.	This	is	further	revealed	in	NO	signaling,	where	O2*-




Beside	 NOX	 and	mitochondria,	 cytosolic	 xanthine	 oxidase	 (XO)	 is	 another	 im-
portant	 source	 of	 oxidants.	 Xanthine	 oxidase	 involves	 in	 purine	 catabolism	 to	
produce	uric	acid	from	hypoxanthine	and	xanthine.	This	reaction	reduces	molec-
ular	oxygen	to	yield	superoxide	(Berry	and	Hare,	2004).	Studies	have	shown	that	
XO	expression,	as	well	as	activity,	 is	 increased	 in	cardiomyocytes	 isolated	 from	














coupling	 reaction	 from	 L-arginine,	 which	 is	 also	 an	 important	 cellular	 oxidant	
(Wagner	 et	 al.,	 2013).	 There	 are	 three	 main	 isoforms	 of	 NOS:	 neuronal	 NOS	












ver,	 iNOS	 protein	 is	 present	 in	 ventricular	 cardiomyocytes	 from	 patients	 with	
end-stage	heart	failure	secondary	to	dilated	cardiomyopathy,	ischemic	heart	dis-
ease,	 or	 valvular	 heart	 disease	 (Haywood	 et	 al.,	 1996).	 Thus,	 it	 is	 still	 under	











addition,	 several	 H2O2-neutralizing	 peroxidases	 exist	 as	 antioxidant	 including	
catalase,	glutathione	peroxidase	(Gpx1),	and	peroxiredoxin	(Prx).	Catalase	is	lo-


















are	 neutralized	 by	 antioxidants	 including	 SOD	 family	 proteins,	 catalase,	 GSH	 and	 Trx	 systems.	
(modified	 from	Lipid	Peroxidation	and	Antioxidants	 in	Arterial	Hypertension.	Teresa	Sousa,	 Jo-






























































1.8.3. Oxidative	 modifications	 of	 functionally	 important	 myocardial	 pro-
teins	and	contractile	dysfunction	
It	 is	known	 that	Ca2+-handling	proteins	are	 important	 substrates	 for	oxidation.	
(Maxwell,	1995).	The	mechanisms	are	incompletely	understood	but	may	involve	
direct	 oxidation	 of	 the	 protein	 or	 upstream	 serine/threonine	 kinases	 or	 phos-


















suggested	 that	 ROS	 can	 decrease	 LTCC	 (Favero	 et	 al.,	 1995;	 Gill	 et	 al.,	 1995;	
Goldhaber	 et	 al.,	 1989;	 Hu	 et	 al.,	 1997;	 Lacampagne	 et	 al.,	 1995),	 SERCA2a	
(Kukreja	et	al.,	1988;	Morris	and	Sulakhe,	1997;	Scherer	and	Deamer,	1986;	Xu	et	













pression.	 For	 example,	 oxidation	 of	 cysteine	 residues	 in	 Kelch-like	 ECH-
associated	protein	1	(Keap1)	changes	its	conformation,	thus	releasing	associated	
nuclear	 factor-erythroid-2-related	 factor	 2	 (Nrf2)	 and	 facilitating	 its	 transloca-
tion	 to	 the	eukaryotic	nucleus.	This	 free	Nrf2	 then	binds	 to	 the	antioxidant	 re-
sponse	 element	 (ARE)	 located	 in	 the	 promoter	 region	 of	 genes	 to	 up-regulate	




nase	 (ERK1/2),	 a	well-established	mediator	 of	 growth	 factor	 signaling	 that	 re-









of	 direct	 oxidative	 activation	 of	 RyR2	may	 give	 protection	 against	 arrhythmia.	
Evidence	 showed	 that	nNOS-	 (which	 is	 colocalized	 to	RyR2)	mediated	RyR2	S-
nitrosylation	 could	 protect	 XO-dependent	 thiol	 oxidation	 and	 heart	 diseases.	













in	 cardiomyocytes	 via	 modulating	 calcium	 current.	 Intracellular	 Ca2+	 concentration	 is	 in-































phoma	2	 (Bcl-2)	associated	X	protein/death	promoter	 (Bax/Bad)	 translocation	
to	mitochondria.	Bax/Bad	translocation	is	mostly	mediated	by	p53,	which	is	ac-
tivated	 by	 oxidant-induced	 DNA	 damage.	 Upon	 activation,	 p53	 induces	Mouse	
double	minute	2	homolog	(MDM2,	an	E3	ubiquitin	ligase)	to	degrade	an	apopto-
sis	repressor	that	interacts	with	Bax	to	inhibit	apoptosis	(Foo	et	al.,	2007).	Evi-
dence	 has	 been	 shown	 that	mice	 deficient	 of	 this	 repressor	 can	 develop	more	




way	 (Remondino	 et	 al.,	 2003).	 This	 is	 in	 agreement	with	 reports	 showing	 that	
either	pressure	overload	(Yamaguchi	et	al.,	2003)	or	MI	(Erickson	et	al.,	2008)	or	






During	acute	coronary	syndrome,	 insufficient	coronary	blood	flow	results	 in	 is-
chemia	and	the	restoration	of	blood	flow	cause	reperfusion.	At	the	cellular	level	
ischemia	 leads	 to	 hypoxia	 and	 reperfusion	 is	 associated	 with	 re-oxygenation	
(Fitzpatrick	and	Karmazyn,	1984).	It	has	been	shown	that	while	free	radicals	are	
generated	 during	 hypoxia,	 vast	 amount	 of	 oxidants	 are	 produced	 during	 re-
oxygenation	by	 the	 respiratory	 chain	 and	other	 enzymes	 like	 xanthine	oxidase	
and	 nitric	 oxide	 synthases	 (Puett	 et	 al.,	 1987;	 Shlafer	 et	 al.,	 1987;	 Zweier	 and	
Talukder,	2006),	which	can	ultimately	damage	myocardium.	This	damage	causes	






tile	 dysfunction	 and	 heart	 failure	 (Ide	 et	 al.,	 2000;	 Ide	 et	 al.,	 1999;	 Kim	 et	 al.,	
2006;	Mulrooney	 et	 al.,	 2009;	 Sag	 et	 al.,	 2011;	 Sag	 et	 al.,	 2013;	 Timolati	 et	 al.,	
2006;	Tokarska-Schlattner	et	al.,	2006).	Evidence	show	NOX2	expression	 levels	
are	 increased	 in	 the	 heart	 early	 after	 acute	myocardial	 infarction	 (MI)	 in	 both	
humans	(Bers,	2008)	and	animal	models.	(Bers	et	al.,	2003)	Part	of	this	increase	
in	NOX2	expression	 is	due	to	 inflammation	associated	migration	of	neutrophils	















production	 from	 the	 juxtaglomerular	 cells	 of	 the	 kidney,	 renin	 is	 released	 pri-
marily	 into	 the	 blood,	 where	 it	 proteolytically	 cleaves	 angiotensinogen	 (pro-
duced	 in	 the	 liver)	 to	 form	 the	 decapeptide	 Angiotensin	 I	 (AngI).	 AngI	 can	 be	
subsequently	 cleaved	 by	 angiotensin	 converting	 enzyme	 (ACE)	 and	 generates	
the	 octapeptide	 AngII	 within	 the	 pulmonary	 circulation	 (Campbell,	 1987;	
Johnston,	1992).	In	addition	to	the	circulating	RAS,	many	other	tissues	can	also	













a	 detrimental	 effect	 on	 the	 heart	 leading	 to	 hypertrophy	 (Harada	 et	 al.,	 1998;	
Kim	et	al.,	1995;	Susic	et	al.,	1996).	Interestingly,	AngII-mediated	cardiac	hyper-
trophy	 followed	by	 cardiac	 remodeling	 is	 characterized	by	 cardiomyocyte	 loss,	









ion	 channels.	 AngII	 increases	 the	 delayed	 rectifier	 potassium	 current,	 Iks	 and	





However,	 AngII	 also	 has	 Gαq	 independent	 signaling	 pathways.	 It	 is	 well	 docu-
mented	that	AngII	can	mediate	some	of	 its	effects	via	directly	stimulating	NOX-
mediated	ROS	 production	 (Zhao	 et	 al.,	 2011).	Moreover,	 Nishida	 et	 al.	 demon-
strated	an	indirect	pathway	where	AT1	stimulation	by	AngII	activates	Gα12/13	pro-





















































dependent	 pathway,	 which	 can	 be	 blocked	 by	 CaMKII	 inhibitor	 KN-93	
(Ichiyanagi	et	al.,	2002;	Zhao	et	al.,	2011).	This	oxidized	CaMKII	can	also	activate	




CaMKII	 signaling	 is	 also	 involved	 in	 AngII-mediated	 hypertrophy.	 It	 has	 been	
demonstrated	that	nuclear	CaMKII	activated	by	envelope	IP3	receptor-mediated	
Ca2+	release	can	cause	histone	deacetylase	(HDAC)	phosphorylation	and	nuclear	
export.	 This	 relieves	HDAC-dependent	 suppression	 of	 cardiomyocyte	 enhancer	
factor	2-driven	 transcriptions	and	contributes	 to	hypertrophy	(Anderson	et	al.,	
2011).	Another	mechanism	of	AngII-mediated	hypertrophy	 could	be	 the	 eleva-
tion	 in	 blood	 pressure	 after	 AngII	 exposure.	 Shear	 stress	 from	 elevated	 blood	
pressure	 can	up-regulate	AngII	 receptors	 (Ruiz-Ortega	et	 al.,	 2001),	which	 fur-
ther	 strengthening	 the	 link	 between	 hypertension	 and	 vascular	 remodeling.	 It	
was	found	that	AngII	infusion	for	two	weeks	can	lead	to	hypertension	and	VSMC	
hypertrophy	 in	 rat	 (Lombardi	 et	 al.,	 1999).	 Evidence	 consistent	with	 a	 central	
role	of	AngII	in	the	pathophysiology	of	heart	failure	also	comes	from	the	fact	that	
the	 AngII	 receptor	 blockers	 or	 ACE	 inhibitors	 are	 clinical	medications	 used	 to	
treat	high	blood	pressure	and	heart	 failure	 (Wen	et	al.,	2012).	 Interestingly,	 as	
mentioned	before,	PKA	can	also	be	activated	by	oxidation,	in	this	thesis,	the	role	












vation	 of	 PKA	 for	 contractile	 function	 under	 physiologic	 conditions.	Moreover,	
the	 importance	 of	 redox-activated	 PKA	 for	 the	 transition	 from	 hypertrophy	 to	
heart	failure	is	evaluated.	Two	different	in	vivo	models	are	used:	the	angiotensin	






2) Angiotensin-dependent	 regulation	 of	 ICa	 includes	 oxidant-dependent	 activa-
tion	of	PKA	type	I,	

















Genetically	modified	mice	 and	 their	WT	 littermates	were	 enrolled	 in	 different	
experiments	of	this	project	to	answer	the	hypothesis.	In	vitro	experiments	were	
done	 with	 isolated	 ventricular	 cardiomyocytes	 from	 these	 mice.	 Moreover,	 KI	
and	WT	mice	were	also	enrolled	for	in	vivo	experiments,	where	they	underwent	
transverse	aortic	constriction	or	chronic	AngII	 infusion.	To	 investigate	contrac-








At	 the	beginning	of	 the	project,	Prkar1	gene	region	of	 the	murine	genome	was	
specifically	amplified	by	PCR.	These	amplified	sequences	were	 then	used	 to	 in-
troduce	a	substituted	mutation	using	site-directed	mutagenesis	at	position	17	of	
exon	 2	 to	 replace	 cysteine	 to	 serine	 (KI).	 An	 FRT-flanked	 neomycin	 selection	
marker	was	inserted	close	to	the	mutation,	which	allows	selection	of	transfected	
embryonic	 stem	 cells	 and	 also	 favored	 homologous	 recombination	 with	 the	
chromosome.	After	screening	by	Southern	blotting	to	identify	if	homologous	re-
combination	had	occurred	 followed	by	validation	of	 the	positive	 clones,	 clones	
were	used	to	transfect	embryonic	stem	cells	to	generate	chimera.	The	chimeras	
were	directly	bred	with	a	Flp	deletor	for	in	vivo	deletion	of	the	selection	marker.	
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the	 deletor	 in	 order	 to	 obtain	 germline	 transmission	 and	 deletion	 of	 selection	
marker	at	the	same	time.	Pure	C57BL/6	mice	were	used	by	Taconic	Artemis	to	
create	this	KI	mouse	line.		







Mice	 lacking	 the	 catalytic	 subunit	of	NOX2,	 gp91phox,	were	used	 in	 this	 study.	
These	mice	had	been	generated	in	the	lab	of	Prof.	Ajay	Shah,	King’s	College	Lon-












centrifuged	 to	 sediment	 the	 hair.	 After	 collecting	 the	 supernatant,	 it	was	 com-
bined	with	PCR	master	mix	 to	amplify	 the	DNA	using	 the	 following	protocol	 in	
PCR	thermocycler	(table.	2.1).		
Amplified	DNA	was	separated	on	1.5%	agarose	gel	in	TBE	buffer	at	120V	for	85	
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Mice	were	 anesthetized	 in	 a	 gas	 chamber	with	 isoflurane	 2-4%	 (Abbott,	 USA).	
After	cervical	dissection,	the	abdomen	was	opened,	and	the	heart	was	carefully	
located	 by	 cutting	 the	 diaphragm	 from	 the	 abdominal	 side.	 The	 heart	 was	 re-
moved	by	gently	cutting	all	vessels	at	the	heart	base	and	then	washed	with	isola-
tion	 buffer.	 The	 ascending	 aorta	 of	 the	 heart	 was	 immediately	 cannulated	 to	
























































eral	 times	 gently	 to	 detach	 cardiomyocytes	 from	 each	 other.	 Cells	 were	 then	
passed	 through	 a	 nylon	 mesh	 to	 remove	 tissue	 debris.	 This	 was	 followed	 by	















these	 superoxide	molecules	 in	 actively	 respiring	mitochondria	 (fig.2.4).	 Oxida-
tion	of	 this	dye	by	 superoxide	 results	 in	2-hydroxyethidium,	which	exhibited	a	
fluorescence	excitation	peak	at	~400	nm	and	emission	at	around	590	nm.	Reac-





































solic	 ROS	 but	 not	 to	 the	 mitochondrial	 or	 nuclear	 ROS.	 The	 CellROX	 dye	 was	
bought	as	a	ready-to-use	stock	solution	containing	2.5	mmol/L	CellROX	in	DMSO.	




















cold	 ethanol	 for	 20-30	minutes	 at	 -20oC.	 After	 fixation,	 the	 cells	were	washed	
with	 1X	 PBS	 (three	 times	 for	 five	 minutes)	 and	 blocked	 with	 5%	 BSA-PBST	
blocking	solution	either	at	room	temperature	for	one	hour	in	a	shaker	or	over-
night	 at	 4oC	 to	 minimize	 nonspecific	 staining.	 After	 blocking,	 cardiomyocytes	
were	washed	with	1X	PBS	(three	times	five	minutes	each)	and	cells	were	subse-
quently	 incubated	with	 primary	 antibody	 (monoclonal	mouse	 anti-PKA	 RI,	 BD	
Transduction	 Laboratories,	 1:100)	 diluted	 with	 antibody	 diluent	 (Dako)	 over-
night	at	4oC.	After	washing	with	1X	PBS	(six	times	five	minutes),	 the	cells	were	






















scope	 (Zeiss	Pascal	5)	using	 laser	 light	at	488	or	555	nm	respectively.	Emitted	
fluorescence	 was	 detected	 by	 a	 photomultiplier	 (emission	 filter:	 560	 nm	 long	
pass	 filter).	 For	 all	 experiments,	 pinhole	 size	was	 set	 at	 1	 airy	unit.	 Cells	were	





crease	 of	 cytosolic	 Ca2+.	 These	 Ca2+	 transients	 are	 underlying	 the	myofilament	
interaction	that	leads	to	contraction.	Inability	to	maintain	proper	Ca2+	transients	
can	 lead	 to	 severe	 impairment	 of	 contractile	 function	 on	 the	 organ	 level.	 To	
measure	the	Ca2+	transients,	the	fluorescent	dye	Fura-2,	an	aminopolycarboxylic	
acid,	 was	 used.	 Membrane	 permeable	 ester	 form	 of	 Fura-2,	 named	 Fura-2-
acetoxymethyl	 ester	 (Fura-2	 AM),	 freely	 diffuses	 across	 the	 cell	 membrane,	
where	 esterases	de-esterify	 the	Fura-2	molecules.	 	With	 time,	 cells	 accumulate	
Fura-2	molecules,	as	the	salt	form	cannot	leave	the	cell,	whereas	the	ester	form	
still	diffuses	into	the	cytoplasm.	Being	a	polar	salt,	Fura-2	can	bind	to	free	intra-
cellular	 Ca2+,	 which	 ultimately	 changes	 its	 fluorescence	 properties.	 The	 Ca2+-
bound	Fura-2	 has	 an	 excitation	maximum	at	 340	nm,	whereas	 the	 free	 Fura-2	
salt	has	its	maximum	at	380	nm.	The	measurement	of	Fura-2	fluorescence	emis-























lows	 de-esterification	 of	 the	 dye	 as	 well	 removal	 of	 the	 excess	 dye	 from	 the	
chamber.	 Temperature	 of	 the	 solution	 was	 maintained	 by	 an	 in-line	 solution	




At	 steady-state	 condition,	 stimulation	 frequency	 was	 increased	 stepwise	 from	
0.5	 to	 4	Hz	 to	 evaluate	 frequency-dependent	 cell	 shortening.	 During	 this	 time,	




emitted	 fluorescence	was	detected	by	a	photomultiplier	 (emission	 filter	at	510	



























sparks	 has	 provided	mechanistic	 insights	 into	 the	 development	 of	 a	 variety	 of	
cardiac	diseases.	Fluo-4	AM,	a	fluorine-substituted	cell	permeable	acetoxymethyl	
ester	 analog	 of	 Fluo-3,	 is	 used	 to	 detect	 Ca2+	 sparks	 in	 intact	 cardiomyocytes.	
Free	unbound	form	of	Fluo-4	is	non-fluorescent,	however,	upon	binding	to	Ca2+,	
excitation	at	488	nm	generates	a	strong	fluorescence	emission	at	516	nm.	More-
over,	 the	change	 in	 fluorescence	emission	 is	greatest	 for	Ca2+	concentrations	 in	
the	range	of	10-1000	nM,	which	renders	the	dye	ideal	for	detection	of	cytosolic	
Ca2+	in	cardiomyocytes.		
Fresh	 mouse	 cardiomyocytes	 were	 plated	 on	 laminin-coated	 chambers	 for	 15	
minutes	to	allow	the	cells	to	attach	to	the	bottom	of	the	chambers.	After	that,	iso-
lation	buffer	was	removed	and	replaced	with	10	μM	of	Fluo-4-AM	dye	dissolved	
in	 Ca2+-free	 Tyrode	 in	 the	 dark	 for	 15	 minutes.	 The	 acetoxymethyl	 ester	 dye	
(AM)	entered	to	the	cell	and	was	hydrolyzed	in	the	cytosol	to	free	salt,	which	can	
bind	 Ca2+	 ions.	 Following	 dye	 loading,	 the	 buffer	 was	 exchanged	 for	 normal	
Tyrode	 solution	 containing	 1	 mM	 Ca2+	 at	 room	 temperature.	 This	 resulted	 in	
washing	out	of	excess	Fluo-4-AM;	however,	only	the	polar	Fluo-4	salt	remains	in	
the	cytoplasm.	
Ca2+	 sparks	were	 recorded	using	 a	 laser	 scanning	 confocal	microscope	 (LSM	5	
Pascal,	Zeiss)	with	a	40×oil-immersion	objective.	Fluo-4	AM	was	excited	via	an	
argon	laser	at	488	nm	and	emitted	fluorescence	was	collected	through	a	515	nm	













After	 manual	 verification,	 Ca2+	 sparks	 were	 analyzed	 according	 to	 frequency	
(normalized	to	cell	volume	and	scan	rate	as	sparks	x	pl-1	x	s-1),	Ca2+	spark	ampli-












Figure	 2.5.	 Schematic	 diagram	 showing	 the	 procedure	 and	 protocol	 for	 whole	 cell	 ICa	
measurement.	 In	 the	 left	 panel,	 diagrams	 show	 the	 principle	 of	 whole	 cell	 patch	 technique,	
where	a	sharp	pipette	is	used	to	attach	to	the	cell	membrane	(1,2,3).	By	applying	a	rapid	suction	
with	 this	pipette,	 the	 cell	 is	 carefully	 ruptured	 (4),	 so	 that	all	 the	 cytoplasmic	 contents	 can	get	
mixed	with	pipette	solution	(5).	Thus,	allowing	 the	measurement	of	Ca2+	currents	at	 single	cell	
level.	Right	panel	shows	the	voltage-step	protocol	used	for	Ca2+	current	recordings.	
Pipette attached  
to the cell 
Mild suction 
Tight contact between 
pipette and membrane 
Strong pulse  
of suction 














from	 control,	 chronic	 AngII	 infused	 or	 pressure	 overload-induced	 mice	 were	
used	to	measure	calcium	current.	At	first	microelectrode	with	a	resistance	of	2-3	





Once	 the	 pipette	was	 attached	 to	 the	 cell	membrane	 and	 a	 giga-ohm	 seal	was	
formed	(Sakmann	and	Neher,	1984),	the	cell	membrane	was	gently	ruptured	by	
application	 of	 rapid	 negative	 pressure	 (i.e.	 suction)	 to	 the	 pipette.	 This	 estab-
lished	an	electrical	access	to	the	cell	with	a	series	resistance	of	<8	MOhm.	Liquid	
junction	potentials	were	corrected,	when	the	pipette	was	in	the	bath.	Then,	the	
fast	 capacitance	 was	 compensated	 in	 cell-attached	 configuration,	 whereas	
membrane	capacitances	were	compensated	after	patch	rupture.	Signals	were	fil-



























ly	good	quality	recordings	with	minimal	or	no	 leak	currents	were	used	 for	 fur-
ther	analysis.	
	
Current-voltage	 (I-V)	 relationship	 was	 determined	 by	 increasing	 the	 voltage	
stepwise	from	–40	mV	to	+80	mV	in	10	mV	steps	from	a	holding	potential	of	–90	
mV	 (fig.2.6).	 Each	 measurement	 pulse	 (duration	 200ms)	 was	 preceded	 by	 a	
50ms	pre-pulse	 to	 -40	mV	 to	 inactivate	 the	 voltage-gated	 sodium	 currents.	 All	





Western	 blot	 technique	 was	 used	 to	 determine	 the	 expression	 and	 post-
translational	 modifications	 of	 Ca2+	 regulatory	 proteins.	 Two	 different	 types	 of	
samples	were	 used	 for	 this	 technique:	 isolated	 cardiomyocytes	 or	whole	mice	
hearts.	 In	 addition,	 human	 atrial	 appendage	 biopsies	 obtained	 from	 patients,	
who	 had	 undergone	 aortocoronary	 bypass	 grafting,	 was	 also	 used.	 These	 pa-
tients	 suffered	 from	 atrial	 fibrillation	 (AF)	 and	 obstructive	 sleep	 apnea	 (OSA).	
For	AF	patients,	mild	 (paroxysmal)	 and	 severe	 (permanent)	AF	were	 analyzed	
separately.	Paroxysmal	AF	means	recurrent	episodes	 that	 stop	on	 their	own	 in	
less	than	7	days;	however,	permanent	AF	means	ongoing	long-term	episodes.	For	




ate	 the	 effect	 of	 H2O2	 on	 Ca2+	 handling	 proteins	 in	 cardiomyocytes.	 After	 that,	
cells	were	 centrifuged,	 and	pellets	were	 lysed	using	 lysis	 buffer	 (table.2.7).	 An	
equal	 volume	 of	 sample	 buffer	 containing	 either	 β-mercaptoethanol	 or	 malei-












bond	 during	 the	 subsequent	 steps	 of	 western	 blot.	 This	 allows	 detecting	 the	
amount	of	oxidized	as	well	as	 reduced	proteins	 in	 the	sample,	which	 is	 in	con-
trast	 to	conventional	western	blot	 technique,	where	β-mercaptoethanol	 is	used	







In	 the	 case	 of	 frozen	 heart	 samples,	 tissue	 was	 pulverized	 and	 suspended	 in	
sample	 lysis	 buffer	 in	 10%	w/v	 ratio.	 Lysed	 samples	were	 immediately	mixed	
with	 2x	 sample	 buffer	 containing	 either	 β-mercaptoethanol	 or	 maleimide;	 re-
spectively	 for	 reducing	 and	 non-reducing	western	 blot	 analysis.	 Samples	were	
then	heated	for	10min	at	55°C	and	kept	in	the	freezer	for	further	electrophoresis	


































After	 electrophoresis,	 proteins	were	 transferred	 to	nitrocellulose	 and/or	PVDF	









10	ml 20	ml 10	ml 20	ml 10	ml 20	ml 5	ml
Rotiphorese	Gel	30	(ml) 2.5 5 3.33 6.66 4.45 8.9 Rotiphorese	Gel	30	(ml) 0.83
4x	Tris/SDS,	pH8.8	(ml) 2.5 5 2.5 5 2.5 5 4x	Tris/SDS,	pH	6.8	(ml) 1.25
ddH2O	(ml) 4.9 9.8 4.1 8.2 2.45 4.9 ddH2O	(ml) 2.86
10%	APS	(µl) 100 200 100 200 100 200 10%	APS	(µl) 50

























































Clear	 supernatants	 were	 collected	 after	 centrifugation	 of	 this	 homogenate	 (at	
10,000	rpm	or	9391	x	g	for	10	min,	at	4°C).	After	that,	neutralizing	reagent,	0.1M	





PKA	RI,	610165 Mouse 3000 BD	Bioscience
PKA	C,	610980 Mouse 3000 BD	Bioscience
PKCα,	ab32376 Rabbit 3000 Abcam
Phospholanban,	05-205 Mouse 15000 Merck	Millipore
p-Phospholamban	Ser	16,A010-12	AP Rabbit 5000 Badrilla
CaMKII,	PA5-22168 Rabbit 10000 Invitrogen
p-CaMKII	Thr	287,	MA1-047 Mouse 4000 Invitrogen
LTCC,	AB5156 Rabbit 5000 Merck	Millipore
RyR2,	HPA020028 Rabbit 15000 Sigma-Aldrich
p-RyR	Ser	2808,	A010-30	AP Rabbit 5000 Badrilla
SERCA	2a,	MA3-919 Mouse 20000 Invitrogen
GAPDH,	BTMC-A473-9 Mouse 30000 Biotrend
a/b-Tubulin,	2148 Rabbit 2500 Cell	Signaling
3%	Goat	serum	blocking	solution
















































temperature.	 After	 repeated	washing	 steps,	 the	 substrate	 (p-nitrophenyl	 phos-
phate)	was	added	to	each	well	to	initiate	the	color	reaction	catalyzed	by	alkaline	
phosphatase.	 Stop	 solution	 was	 added	 1	 hour	 after	 adding	 the	 substrate.	 The	
plate	was	 then	 directly	 used	 to	measure	 the	 absorbance	 of	 light	 at	 405	 nm	 to	








Histochemical	 experiments	 were	 performed	 on	 5μm	 thick	 paraffin-embedded	
cross	sections	of	whole	hearts	from	six	weeks	TAC	or	AngII	mice.	Then,	cardiac	
fibrosis	 and	morphology	were	 examined	 using	Masson’s	 trichrome	 (MTC)	 and	
Hematoxylin-Eosin	 (H/E)	 staining	 on	 these	 tissue	 sections.	 Briefly,	 for	 MTC	
staining,	 after	 xylene-	 and	 graded	 alcohol	 (100-50%)-mediated	 deparaffiniza-




and	 acetic	 acid	 solution.	 Finally,	 slides	were	 dehydrated	 and	 fixed	with	 Histo-
mount	for	later	analysis	(table.2.11).	
y = -0.79ln(x) + 1.576 



























Transverse	 aortic	 constriction,	 TAC,	 is	 a	 common	method	 to	 provoke	pressure	
overload-induced	cardiac	hypertrophy	and	heart	 failure	 in	mice,	which	mecha-
nistically	mimics	human	aortic	stenosis	(Rockman	et	al.,	1991).	In	this	method,	a	
knot	 is	made	onto	 the	 transverse	aorta	 located	between	 the	origin	of	 the	 right	
innominate	and	left	common	carotid	arteries.	This	initially	leads	to	compensated	















































to	 antagonize	 the	 anesthesia	 and	maintain	 analgesia.	 Moreover,	 pain	 manage-
ment	 was	 controlled	 by	 daily	 treatment	 with	 1.33	 mg/ml	 metamizole	 in	 the	
drinking	water	starting	two	days	before	the	surgery,	which	continued	for	seven	




few	mice	underwent	programmed	electrical	 stimulation	 (see	below)	or	 in	vitro	
electrophysiological	experiments.	Hearts	were	also	harvested	at	this	time	point	























serted	 to	each	pump	with	a	 filling	 tube.	Flow	moderators	were	carefully	 intro-
duced,	and	the	pumps	were	maintained	in	upright	position	until	implanted	into	
to	the	mice.	The	weights	of	pumps	were	measured	before	and	after	the	filling	to	





to	 insert	 the	pump.	Body	 temperature	was	maintained	at	37°C	using	a	 thermal	
pad.	The	mouse	was	then	prone	positioned.	After	removing	hair	from	the	neck,	a	





mice.	All	 these	mice	were	grouped	and	 followed	either	 two	or	six	weeks	of	 the	
implantation.	 During	 this	 time,	 heart	 function	was	monitored	 via	 echocardiog-





The	 CODA	 mouse	 rat	 tail-cuff	 system	 (Kent	 Scientific),	 which	 uses	 volume-
pressure	 recording	 (VPR)	 sensor	 technology,	was	used	 to	measure	 the	mouse-
tail	 blood	 pressure.	 	 The	 mouse	 was	 anesthetized	 with	 2%	 isoflurane	 in	 1.0	
L/min	 100%	 O2	and	 inserted	 into	 a	 clear	 acrylic	 tube	 with	 nose	 cone	 holder	
(Kent	 Scientific)	 to	 restrict	 its	movements	 and	 to	 avoid	 artifacts	 from	 the	 cuff	
measurements.	 After	 that,	 the	 tube	 containing	 the	mouse	was	mounted	 onto	 a	
heating	plate,	so	that	mouse	could	wake	up	and	get	used	to	with	the	tube.	After	
its	acclimatization	to	the	tube	for	at	least	half	an	hour,	the	cuff	was	mounted	on	














back	 temperature	control).	After	 removal	of	 fur	by	hair	 removing	cream	(Veet,	
Unilever),	 the	ultrasound	transducer	(30	MHz	center	 frequency)	was	placed	on	
















ventilation	 using	 2%	 isoflurane	 in	 1.0	 L/min	 100%	 O2,	 27-gauge	 needle	 elec-
trodes	were	subcutaneously	placed	on	each	 limb	of	 the	head	back	supine	posi-
Functional	parameters:
Fractional	Area	Shortening,	% FAS (Area	d-Area	s)/	Area	d	x	100 ELABORATION
Fractional	Shortening,	% FS (LVID	d-LVID	s)/	LVID	d	x	100 d=	diastole
Volume	in	Systole,	μl Vol	s 5/6	x	Area	s	x	L	s s=	systole
Volume	in	Diastole,	μl Vol	d 5/6	x	Area	d	x	L	d LVID=	left	ventricular	inner	diameter
Ejection	Fraction,	% EF (Vol	d-Vol	s)/Vol	d	x	100 L=	length
Stroke	volume,	μl SV Vol	d-Vol	s Vol=	volume
Cardiac	Output,	μl/min CO SV	x	HR HR=	heart	rate











made	 in	 the	 vein,	 and	 a	1.1F	octapolar	 catheter	 (EPR-800;	Millar	 Instruments)	
was	introduced	until	its	tip	lead	reached	to	the	right	ventricular	(RV)	apex	close	
to	the	diaphragm.	A	proximal	ligature	was	also	made	to	the	jugular	vein	to	avoid	
bleeding.	 Optimal	 position	 was	 figured	 out	 using	 bipolar	 RV	 stimulation	 (be-
tween	the	tip	lead	and	the	lead	next	to	it),	which	was	monitored	by	simultaneous	

































blot,	 immunohistochemistry,	 immunocytochemistry	 and	 fluorescent	 images	






































































































































































































































































Angiotensin	 II	 (AngII)	 and	 pressure	 overload	 both	 have	 been	 accused	 of	 ar-




species	 (Dikalov	 and	 Nazarewicz,	 2013;	 Schwarzer	 et	 al.,	 2014;	 Takimoto	 and	
Kass,	 2007).	 Here	 in	 this	 thesis,	 it	 was	 hypothesized	 that	 AngII-	 and	 pressure	
overload-implicated	these	pathophysiological	changes	via	the	production	of	ROS,	




Upon	 stressed	 conditions,	 cells	 produce	 AngII	 to	 initiate	 several	 downstream	
signaling	 to	 cope	 up	with	 the	 stress	 (Sachse	 and	Wolf,	 2007).	 In	 order	 to	 test,	
whether	this	AngII	can	induce	oxidant	production	on	cardiomyocytes,	1	μM	An-
gII	was	added	to	the	isolated	ventricular	myocytes,	which	robustly	increased	cy-
tosolic	 ROS	 production	 as	 assessed	 by	 CellROX	 in	 a	 time-dependent	 manner	
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Figure	 3.1.	 In	 vitro	 application	 of	 AngII	 increases	
cytosolic	 ROS	 production.	Original	 recordings	 (A,	 left)	 and	
quantitative	 data	 represented	 as	 mean±standard	 error	 (B,	
right).	 	 Isolated	 mouse	 ventricular	 cardiomyocytes	 loaded	
with	 cytosolic	 ROS	 indicator,	 CellROX	 and	 exposed	 to	 either	
vehicle	or	AngII.	For	improved	visualization,	grayscale	values	
were	 converted	 to	 color	 using	 the	 depicted	 calibration	 bar	
(A).	Both	WT	and	KI	cardiomyocytes	produced	oxidants	upon	
AngII	 exposure.	 At	 10	min	 or	 7	min,	 CellROX	 fluorescence	
(F/F0)	 intensity,	were	 increased	significantly	either	 in	WT	or	
KI	 cardiomyocytes	 compared	 to	 control,	 respectively	 (B).	 At	





Compared	 to	 baseline	 (0min),	 CellROX	 fluorescence	 became	 significantly	 in-
creased	 7	min	 after	 initial	 exposure	 to	 AngII	 (to	 1.13±0.05,	 fig.3.1).	 Similarly,	






Since	 it	 is	known	that	 increased	amount	of	cytosolic	ROS	can	diffuse	 into	mito-
chondria	 to	stimulate	mitochondrial	ROS	production	by	a	ROS-induced	ROS	re-
lease	mechanism,	mitochondrial	 ROS	 production	was	 tested	 using	MitoSOX.	 In	
order	to	test	the	effect	of	AngII	on	mitochondrial	ROS	production,	 isolated	ven-
tricular	cardiomyocytes	were	exposed	to	AngII	 in	 the	presence	of	MitoSOX.	Ex-





















could	not	 produce	ROS	 (bottom,	 right).	 At	 least	 three	 independent	mice	were	used	per	 group;	
ANOVA	was	used	for	statistics;	*	means	P<0.05.	
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WT, vehicle, n=11
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KI+ Ang II, N=5
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be	 significantly	 increased	 at	 7	min	 (Vehicle	 vs.	 AngII,	 0.97±0.04	 vs.	 1.06±0.02,	
fig.3.2).	 Interestingly,	 this	 AngII-dependent	 increases	 in	 MitoSOX	 fluorescence	
was	 completely	 abolished	 in	 cardiomyocytes	 lacking	 the	 catalytic	 subunit	 of	
NADPH	 oxidase	 2	 (gp91phox	 knockout	 mice),	 suggesting	 that	 sarcolemmal	




Brennan	et	al.	 showed	 that	oxidants	could	 induce	an	 intermolecular	dimer	 for-
mation	and	activate	type	I	PKA	that	ultimately	phosphorylates	downstream	tar-





Figure	 3.3.	 Oxidant-induced	 PKA	 RI	 dimer	 formation.	 Original	 recordings	 (A,	 left)	 and	
quantitative	data	represented	as	mean±standard	error	(B,	right).		In	the	presence	of	H2O2,	PKA	RI	
subunit	of	isolated	mouse	ventricular	cardiomyocytes	got	oxidized	(A,	left)	and	form	significantly	
higher	 intermolecular	 disulfide	 bond	 compared	 to	 control	 (A,	 right).	 Upon	 AngII	 perfusion	 to	
isolated	 whole	 heart,	 WT	 produced	 significantly	 higher	 PKA	 RI	 disulfide	 bonds	 compared	 to	





erates	 other	 ROS	 as	 well	 (superoxide,	 hydroxyl	 radicals,	 etc.)	 (Burdon,	 1995).	
Figure	 3.3	 shows	 in	WT	 cardiomyocytes;	 RI	 dimer	 formation	was	 increased	 in	
the	 presence	 of	 H2O2	 (100	 µM).	 Densitometric	 analysis	 revealed	 that	 H2O2	 -
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of	 action	 potential.	 Moreover,	 scientists	 reported	 that	 LTCC	 could	 be	 the	 sub-
strate	of	type	I	PKA	rather	than	type	II	(Burton	et	al.,	1997;	Jones	et	al.,	2012).	In	
order	to	test,	whether	oxidized	type	I	PKA	phosphorylates	the	alpha	subunit	of	
LTCC	 (CaV1.2),	 I	 exposed	 Langendorff-perfused	 hearts	 to	 AngII	 (1	 µM)	 for	 10	
min.		
																						 																		
Figure	 3.4.	 	 AngII-dependent	 LTCC	 phosphorylation	 is	 mediated	 by	 oxidative	 PKA	
activation.	Original	recordings	(left)	and	quantitative	data	represented	as	mean±standard	error	
(right).	 Whole	 heart	 perfusion	 with	 AngII-induced	 substrate	 phosphorylation	 at	 PKA	 site,	 as	
shown	by	 the	 quantitative	 data.	 In	WT,	 LTCC	phosphorylation	 increased	 compared	 to	KI	 upon	






























































Figure	3.5	 shows	 the	 subcellular	distribution	of	PKA	RI.	Compared	 to	baseline,	
AngII	stimulation	resulted	in	a	significant	increase	in	membrane-associated	PKA	
RI.	Region	of	 interest	(ROI)	analysis	of	fluorescence	intensity	at	T-tubules	(TT),	
intercalated	 disc	 (ICD)	 and	 nucleus	 revealed	 that	 AngII	 significantly	 increased	
fluorescence	intensity	compared	to	baseline	(fig.3.5)	in	these	ROI	suggesting	in-
creased	association	with	possible	target	proteins.	Quantitative	data	for	ROIs	for	




quantitative	 data	 represented	 as	 mean±standard	 error	 (B,	 right).	 Isolated	 mouse	 ventricular	
cardiomyocytes,	 in	 the	 presence	 of	 AngII	 (1	 μM),	 showed	 significantly	 higher	 membrane	 and	
nuclear	 translocation	 of	 PKA	 RI	 subunit.	 For	 improved	 visualization,	 grayscale	 values	 were	
converted	to	color	using	the	depicted	calibration	bar.	Mean	data	showed	that,	upon	AngII,	PKA	RI	
predominantly	translocate	to	the	intercalated	disc	(ICD),	T-tubules	(TT)	and	the	nucleus	from	the	
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ingly,	 exposure	 of	AngII	 to	KI	 cardiomyocytes	 resulted	 in	 significantly	 reduced	




traces	 showing	 baseline	 calcium	 transients	 from	 WT	 and	 KI	 mice.	 Fura-2-loaded	 WT	 and	 KI	
cardiomyocytes	were	stimulated	with	different	beating	frequencies	to	evaluate	their	contractile	
ability	(B,	top).		In	the	presence	of	AngII	(1	μM),	WT	cardiomyocytes	can	maintain	Ca2+	transient	























































































































































be	 used	 as	 a	 measure	 of	 SR	 Ca2+	 content.	 Interestingly,	 AngII	 dramatically	 re-
duced	 caffeine-induced	 Ca2+	 transients	 in	 both	 WT	 and	 KI	 cardiomyocytes	
(fig.3.7).	While	 there	was	a	 small	difference	 in	 caffeine-transient	amplitude	be-
tween	 WT	 and	 KI	 cardiomyocytes	 at	 baseline	 (WT	 vs.	 KI;	 1.41±0.11	 vs.	
0.94±0.14,	 P<0.05),	 no	 difference	was	 observed	 in	 the	 AngII-dependent	 reduc-
tion	(0.43±0.06	vs.	0.35±0.09,	fig.3.7).	 	After	correcting	the	baseline	differences,	
it	was	 found	 that	AngII	 reduces	caffeine-transient	amplitude	 in	WT	and	KI	 to	a	




Figure	 3.7.	 Reduction	 of	 SR	 Ca2+	 contents	 upon	 AngII.	 Original	 data	 on	 top	 (A)	 and	
quantitative	data	 represented	as	mean±standard	error	on	 the	bottom	panel	 (B).	Fura-2-loaded	
WT	and	KI	cardiomyocytes	were	stimulated	with	0.5	Hz	beating	frequency	to	evaluate	their	SR	
Ca2+	 content.	 	At	baseline,	KI	had	 less	SR	 content	 (A).	 In	 the	presence	of	AngII	 (1	μM),	 SR	Ca2+	

























































































































The	RyR2	 function	was	evaluated,	 to	 identify	 the	dramatic	AngII-dependent	re-
duction	in	SR	Ca2+	content.	Because	SR	Ca2+	content	is	mainly	determined	by	SR	
Ca2+	leak	through	ryanodine	receptor	and	Ca2+	reuptake	by	SERCA2a.	It	has	been	
reported	 that	 the	kinetics	of	 the	Ca2+	 transient	decay	 in	mice	directly	 correlate	
with	SERCA2a	function	(Bers,	2001).	Therefore,	Ca2+	transient	decay	characteris-
tics	were	investigated	by	fitting	the	decay	to	a	monophasic	exponential	equation.	
The	 time	 constant	 (tau)	of	 the	 fit,	 which	 is	 a	measure	 of	Ca2+	 transient	 decay,	
however,	was	not	significantly	altered	by	AngII	exposure	(fig.3.6),	suggesting	that	




Ca2+	 leak,	 Ca2+	 sparks	 were	 measured	 in	 isolated	 ventricular	 cardiomyocytes	
loaded	with	Fluo-4	 (10	µM,	 fig.3.8).	Original	 line	 scans	 and	mean	data	 for	Ca2+	
spark	 frequency	 (CaSpF)	 revealed	 that	 AngII	 dramatically	 increased	 diastolic	














(1	 μM),	 both	 WT	 and	 KI	 had	 significantly	 higher	 spark	 frequency	 (B,	 right).	 However,	 this	
increase	in	spark	frequency	is	independent	of	PKA,	as	H89	(a	PKA	inhibitor)	could	not	decrease	




between	WT	 and	 KI	 cardiomyocytes.	 Further	 evidence	 for	 a	 PKA-independent	

























































ine	 1928	 (see	 above),	 which	 could	 alter	 the	 LTCC-dependent	 Ca2+	 influx	 (ICa).	
Moreover,	reduced	SR	Ca2+	content	but	unaltered	Ca2+	transient	amplitude	upon	
AngII	exposure	may	be	explained	by	compensatory	increases	in	ICa.		Therefore,	ICa	






at	 0mV	 (C).	 I-V	 curve	 and	peak	 data	 showed	 that	 both	WT	 and	KI	 had	 comparable	 peak	 ICa	 at	




decreased	 ICa	from	baseline	 level.	D)	 Interestingly,	 cAMP	 levels	were	 increased	 in	KI	 vs.	WT	 at	
baseline.	Quantitative	data	represented	as	mean±standard	error.	At	least	three	independent	mice	
were	used	per	group;	ANOVA	was	used	 for	statistics;	 in	A:#	means	P<0.05	vs.	vehicle,	 *	means	
P<0.05	vs.	AngII;	in	C	&	D:	*	means	P<0.05.	





























































































































7.47±0.23	A/F	 (vehicle	 vs.	 AngII,	 P<0.05).	 Interestingly,	 the	PKA	 inhibitor	H89	
(10	µM)	could	completely	abolish	this	AngII-dependent	 increase	in	ICa	(peak	ICa	
at	 0	 mV	 -5.27±0.30	 A/F,	 P<0.05	 vs.	 AngII,	 fig.3.9).	 In	 sharp	 contrast,	 AngII	
exposure	did	not	affect	ICa	in	cardiomyocytes	expressing	redox-dead	type	I	PKA	
RI	 (KI,	 fig.3.9)	 suggesting	 that	 AngII-dependent	 impairment	 of	 Ca2+	 transient	
amplitude	in	KI	may	indeed	be	due	to	lack	of	ICa	stimulation.	In	KI,	peak	ICa	at	0	
mV	was	-6.84±0.55	vs.	-6.97±0.36	A/F	(vehicle	vs.	Ang	II,	p=N.S.).	 Interestingly,	
at	 baseline,	 I	 observed	 an	 increased	 ICa	 amplitude	 in	 KI	 cardiomyocytes	
(compared	to	WT,	fig.3.9),	which	could	be	blocked	by	H89	(fig.3.9)	suggesting	a	









Figure	 3.10.	 AngII	 increases	 open	 probability	 of	 calcium	 channel	 via	 oxidized	 PKA.	 ICa	
activation	 curve	 (A),	 with	 relative	 conductance	 derived	 from	maximal	 chord	 conductance	 and	
reversal	potential	 (Erev)	 for	each	 I–V,	and	peak	 ICa/(Em−Erev).	The	 resulting	conductance	was	
normalized	to	the	maximal	chord	conductance	(usually	between	10	and	20	mV).	Data	was	fit	to	a	
standard	Boltzmann	equation.	Panel	B:	Quantitative	voltage	data	for	half-activation	(V50).	AngII	
negatively-shifted	 the	 ICa	 activation	 curve,	 and	 this	 was	 blocked	 with	 H89.	 However,	 this	
phenomenon	 was	 completely	 absent	 in	 KI.	 Quantitative	 data	 represented	 as	 mean±standard	
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ICa	 steady-state	 activation	 gating	 was	 also	 investigated	 by	 measuring	 slope	
conductance	 at	 voltage-steps	 increasing	 from	 –40	 to	 80	 mV,	 to	 further	
understand	 the	 mechanism	 of	 ICa	 regulation	 by	 oxidized	 PKA.	 The	 slope	
conductance	was	 then	 normalized	 to	maximal	 conductance	 (G/Gmax,	 fig.3.10).	
Excitingly,	 in	 WT	 cardiomyocytes	 AngII	 significantly	 shifted	 the	 steady-state	
activation	 curve	 by	 about	 2	 mV	 towards	 more	 negative	 potential.	 Therefore,	
reduced	 the	 voltage	 at	 half-maximal	 activation	 (V50)	 from	 -14.54±0.32	 to	 -
16.02±0.22	mV	 (P<0.05,	 fig.3.10)	 in	WT	 cardiomyocytes.	 This	 leftward	 shift	 in	
the	activation	curve	was	blocked	by	pre-incubating	the	cardiomyocytes	with	H89	
(V50:	 -14.68±0.24	 mV,	 P<0.05	 vs.	 AngII).	 	 Interestingly,	 this	 AngII-dependent	
shift	 in	 the	 activation	 curve	was	 completely	 absent	 in	KI	 cardiomyocytes	 (V50	
was	-13.88±0.27	vs.	-14.01±0.31	mV,	vehicle	vs.	AngII,	P=N.S.,	fig.3.10),	suggest-
ing	 that	oxidized	PKA	type	 I	may	be	 involved	 in	Ca2+	channel	gating.	 In	accord-




In	 vitro	 contractile	 data	 showed	 no	 difference	 in	 WT	 and	 KI	 cardiomyocyte	





















































Analysis	 of	 basic	 surface	 electrocardiograms	 also	 revealed	 no	 differences	 in	
heart	 rate,	 intra-arterial,	 atrioventricular	 or	 intraventricular	 conduction	 or	 re-
polarization	(table	3.2).	
	





diomyocytes,	 induced	 cytosolic	 ROS	 production,	mouse	 ventricular	 cardiomyo-
cytes	were	isolated	two	weeks	after	osmotic	minipump	mediated	infusion	of		
Number
HR	(bpm) 407.667 ±11.176 440.882 ±35.795
RR	(min-1) 119.267 ±8.031 120.643 ±12.814
BT	(°C) 37.187 ±0.250 37.350 ±0.314
BW	(g) 22.680 ±0.808 21.594 ±0.699
FS	(%) 22.983 ±1.228 23.230 ±1.338
SV	(µl) 40.329 ±2.246 38.225 ±1.982
CO	(ml/min) 16.389 ±0.989 16.887 ±1.562
CI	(µl/min/g) 731.855 ±47.131 787.962 ±76.519
LVIDd	(mm) 4.468 ±0.081 4.330 ±0.069
LVIDs	(mm) 3.446 ±0.097 3.327 ±0.085
Vol	s	(µl) 51.721 ±3.876 44.476 ±2.438
Vol	d	(µl) 92.050 ±4.985 82.701 ±3.317
AWThd	(mm) 0.651 ±0.022 0.618 ±0.026
PWThd	(mm) 0.550 ±0.022 0.519 ±0.021
AWThs	(mm) 0.955 ±0.033 0.918 ±0.033
PWThs	(mm) 0.786 ±0.023 0.747 ±0.034
Ls	(mm) 7.035 ±0.116 6.869 ±0.092






RR	Interval	(s) 0.124 ±0.0042 0.123 ±0.0049
Heart	Rate	(BPM) 488.933 ±17.5835 491.186 ±18.7127
PR	Interval	(s) 0.036 ±0.0013 0.037 ±0.0015
P	Duration	(s) 0.007 ±0.0005 0.010 ±0.0017
QRS	Interval	(s) 0.008 ±0.0004 0.008 ±0.0005
QT	Interval	(s) 0.019 ±0.0019 0.019 ±0.0029
QTc	(s) 0.054 ±0.0055 0.055 ±0.0084
JT	Interval	(s) 0.011 ±0.0019 0.011 ±0.0028
Tpeak	Tend	Interval	(s) 0.009 ±0.0018 0.009 ±0.0029
P	Amplitude	(mV) 0.138 ±0.0104 0.101 ±0.0268
Q	Amplitude	(mV) -0.011 ±0.0083 -0.020 ±0.0157
R	Amplitude	(mV) 0.874 ±0.0863 0.935 ±0.0694
S	Amplitude	(mV) -0.202 ±0.0351 -0.246 ±0.0566
ST	Height	(mV) 0.098 ±0.0187 0.086 ±0.0101
















After	 two	weeks	 of	 AngII	 infusion,	mice	 hearts	were	 analyzed	 to	 test	whether	
chronic	AngII	 infusion	can	cause	PKA	oxidation	 like	 in	vitro	 experiments.	Com-
pared	 to	vehicle	 infusion	 (control,	CTRL),	 two	weeks	exposure	 to	AngII	 signifi-
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Figure	 3.12.	 Chronic	 AngII	 infusion	 induces	 oxidant	
production	both	 in	WT	and	KI	mice.	Original	recordings	
(A,	 left)	 and	 quantitative	 data	 represented	 as	
mean±standard	 error	 (B,	 right).	 Mice	 carried	 AngII	
containing	 OMP	 produced	 significantly	 higher	 oxidants	 as	
visualized	 by	 increased	 fluorescent	 signal	 from	 isolated	
ventricular	 cardiomyocytes	 loaded	 with	 cytosolic	 ROS	
indicator	 CellROX.	 For	 improved	 visualization,	 gray	 scale	
values	 were	 converted	 to	 color	 using	 the	 depicted	
calibration	bar	(A).	Quantitative	data	also	a	showed	similar	
pattern	in	WT	and	KI.	At	least	 two	independent	mice	were	










RI	 dimer	 was	 increased	 in	WT	mice	 compared	 to	 KI	 upon	 two	weeks	 of	 AngII	 infusion	 using	














Interestingly,	 there	was	 a	 tendency	 towards	 reduced	 expression	 of	 LTCC	upon	
AngII	infusion	in	both	WT	and	KI	mice	(fig.3.14).	Since	acute	AngII	exposure	also	















































































































Figure	 3.14.	 Chronic	 AngII-induced	 activation	 of	 PKA	 type	 I	 cause	 subsequent	 substrate	
phosphorylation.	 Oxidized	 PKA	 was	 considered	 as	 a	 phosphorylating	 agent	 for	 different	
substrates,	 like	 L-type	 Ca2+	 Channel,	 Phospholamban,	 as	 shown	 in	 panel	 A.	 Although,	 the	
expressions	were	unchanged	for	LTCC,	PLB,	SERCA2a	and	RyR2;	the	PKA	phosphorylation	sites	
were	significantly	more	phosphorylated	in	WT	compared	to	control.	KI	mice	could	not	show	this	
phenomenon,	 indicating	 oxidized	PKA	 is	 involved.	 RyR2	 also	did	not	 show	 this	 oxidative	PKA-





lation	 at	 S2808	 upon	AngII	 exposure,	 this	 increase	was	 not	 significant	 for	WT	
and	KI	mice	 (WT,	 CTRL	 vs.	 AngII,	 0.81±0.14	 vs.	 1.02±0.12;	 KI,	 CTRL	 vs.	 AngII,	
1.06±0.08	 vs.	 1.19±0.16;	 fig.3.14).	 In	 contrast,	 AngII	 exposure	 significantly	 in-
creased	 PKA-dependent	 PLB	 phosphorylation	 at	 S16	 in	WT	 animals	 (CTRL	 vs.	


























































































































































































































































































































































increased	 CaMKII	 expression	 with	 no	 difference	 between	 WT	 and	 KI	 mice	
(fig.3.15).	In	WT	animal	compared	to	control,	AngII	increased	CaMKII	expression	
from	1.01±0.06	to	1.33±0.10,	P<0.05,	fig.3.15).	In	KI	mice	CaMKII	expression	was	





Figure	 3.15.	 Effects	 of	 AngII	 on	 CaMKII	 and	 PKC	 expression.	 CaMKII	 and	phospho-CaMKII	








functions,	 to	 test	 whether	 AngII-induced	 PKA	 type	 I-dependent	 regulation	 of	
LTCC	is	essential	 for	contractile	 function.	Figure	3.16	shows	original	 traces	(M-
mode)	and	mean	data	for	echocardiography	in	mice	after	two	weeks	exposure	to	
AngII.	Similar	to	the	acute	exposure	of	AngII	in	ventricular	cardiomyocytes,	two	



































































































































































that	 KI	 had	 reduced	 cardiac	 function	 compared	 to	 WT	 and	 control	 (A).	 Quantitative	 data	
represented	 as	 mean±standard	 error	 showing	 less	 ejection	 fraction	 and	 fractional	 area	
shortening	in	KI	compared	to	WT	littermates	(B).	Upon	two	weeks	of	AngII	infusion,	both	WT	and	
KI	 had	 increased	 blood	 pressure	 compared	 to	 the	 control	 (C).	 MTC	 and	 Hematoxylin	 staining	
showed	that	similar	morphology	of	whole	heart	sections	upon	AngII	 infusion	 in	both	groups	of	
mice.	Although	WT	showed	more	hypertrophy	compared	to	KI	as	reveled	by	heart	weight	to	body	
weight	 ratio	 (C),	 both	 the	mice	had	 a	 similar	 level	 of	 fibrosis.	At	 least	 three	 independent	mice	
were	used	per	group.	ANOVA	was	used	for	statistics;	*	means	P<0.05.		
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ly	 increased	mean	 arterial	 blood	 pressure	 in	 both	WT	 and	 KI	 animals.	 In	WT	








ized	 to	 body	 weight)	 with	 no	 significant	 difference	 between	WT	 and	 KI	 mice.	
Immunohistochemistry	 was	 performed	 to	 investigate	 whether	 altered	 cardiac	
function	is	due	to	their	hypertrophic	or	fibrotic	responses	upon	AngII.	Masson's	
trichrome	 and	H/E	 staining	 showed	 that	 both	WT	 and	 KI	 animals	 had	 similar	






In	order	 to	 test,	whether	Ca2+	 channel	dysregulation	 indeed	underlies	 the	 con-
tractile	dysfunction	observed	in	KI	mice	upon	AngII	exposure,	Ca2+	channel	activ-
ities	was	measured	 using	 the	whole	 cell	 patch	 clamp	 technique	 and	 compared	
Number
HR	(bpm) 430.000 ±21.707 431.286 ±12.944 445.300 ±12.957 424.100 ±14.164
RR	(min-1) 108.857 ±16.338 123.417 ±8.800 115.125 ±16.138 124.500 ±6.544
BT	(°C) 37.250 ±0.290 37.114 ±0.216 37.240 ±0.327 36.890 ±0.261
BW	(g) 26.063 ±1.099 26.457 ±0.934 26.460 ±1.153 28.600 ±1.105
FS	(%) 25.632 ±1.117 25.417 ±1.652 24.716 ±2.234 21.259 ±1.634
SV	(µl) 45.509 ±4.636 43.223 ±2.410 42.938 ±2.611 39.819 ±2.462
CO	(ml/min) 19.798 ±2.517 18.633 ±1.137 19.207 ±1.411 17.129 ±1.463
CI	(µl/min/g) 747.175 ±69.978 711.007 ±43.876 729.862 ±53.645 596.835 ±45.232
LVIDd	(mm) 4.407 ±0.150 4.364 ±0.117 4.352 ±0.146 4.433 ±0.103
Vol	s	(µl) 43.752 ±4.303 47.017 ±4.235 46.404 ±5.500 52.092 ±5.701
Vol	d	(µl) 89.261 ±7.575 90.240 ±5.414 89.342 ±7.049 91.911 ±6.660
PWThd	(mm) 0.538 ±0.040 0.608 ±0.029 0.603 ±0.020 0.636 ±0.042
AWThs	(mm) 0.985 ±0.065 1.068 ±0.038 0.990 ±0.025 1.012 ±0.043
PWThs	(mm) 0.762 ±0.032 0.861 ±0.038 0.758 ±0.033 0.825 ±0.048
Ls	(mm) 7.089 ±0.174 7.223 ±0.166 7.059 ±0.175 7.106 ±0.300
Ld	(mm) 8.000 ±0.192 8.092 ±0.130 7.908 ±0.183 8.112 ±0.230
10 108 14










two	weeks	of	AngII	exposure	 (A).	 In	WT	mice,	peak	 ICa	was	not	altered.	A)	Original	 traces	 (left	
panel)	 and	 IV	 protocol	 (right	 panel)	 for	 current-voltage	 relationship	 B)	 Quantitative	 data	








by	 western	 blot.	 Mean	 data	 for	 ICa	 at	 0	 mV	 were	 -5.99±0.33	 vs.	 -5.39±0.23	
(P=N.S.)	 A/F,	 for	 CTRL	 vs.	 AngII	 in	 WT,	 and	 -6.14±0.34	 vs.	 -4.82±0.23	 A/F	
(P<0.05)	for	CTRL	vs.	AngII	in	KI	(fig.3.17).		
	
Intracellular	 Ca2+	 handling	was	 investigated	 in	 isolated	 ventricular	 cardiomyo-
cytes	loaded	with	the	Ca2+	indicator	Fura-2	(10	µmol/L,	20	min),	to	understand	
further	the	mechanisms,	which	leads	to	contractile	dysfunction	in	KI	mice	after	

















































recorded	 in	vivo,	 there	was	no	difference	 in	Ca2+	 transient	amplitude	upon	 two	
weeks	AngII	exposure	to	WT	cardiomyocytes	(fig.3.18).	In	sharp	contrast,	AngII	
exposure	 dramatically	 reduced	 Ca2+	 transient	 amplitude	 in	 KI	 cardiomyocytes	
(fig.3.18).	 At	 0.5	 Hz,	 mean	 Ca2+	 transient	 amplitudes	 were	 0.20±0.03	 vs.	












Interestingly,	 despite	 unchanged	 Ca2+	 transient	 amplitude,	 a	 dramatically	 re-
duced	 SR	 Ca2+	 content	 in	WT	 cardiomyocytes	was	 found	 by	 caffeine	 exposure	
upon	 chronic	AngII	 exposure.	 In	WT,	AngII	 exposure	 significantly	 reduced	 caf-








AngII-dependent	 reduction	 in	 SR	 Ca2+	 content,	 may	 be	 due	 to	 increasing	 frac-
tional	Ca2+	release	from	the	SR	(Ca2+	transient	amplitude	normalized	to	Ca2+	cur-
rent).	 AngII	 exposure	 strongly	 increased	 fractional	 release	 from	 2.289	 to	
3.49±0.72	%,	 P<0.05,	 fig.3.18).	 In	 KI,	 however,	 fractional	 Ca2+	 release	was	 not	








Figure	 3.18.	 Oxidative	 PKA	 activation	modulates	 Ca2+	 transient	 but	 not	 Ca2+	 spark	 upon	




reuptake	 was	 slower	 in	 KI	 mice	 exposing	 to	 AngII	 (B).	 Representative	 caffeine-induced	 Ca2+	
transients	 showed	 both	 WT	 and	 KI	 had	 reduced	 SR	 calcium	 content	 upon	 AngII,	 but	 KI	 had	
significantly	lower	Ca2+	content	compared	to	WT	and	control	(C,	bottom).	Fractional	release	data	
also	showed	 that	WT	cardiomyocytes	 increased	 fractional	 release	upon	AngII	but	KI	could	not.	










































































































































































































































































































of	 reduced	SR	Ca2+	 content	 further	by	measuring	spontaneous	elementary	Ca2+	
release	events	(i.e.	Ca2+	sparks)	using	confocal	microscopy.	Figure	3.18	show	that	
AngII	 strongly	 increased	Ca2+	 spark	 frequency	with	no	difference	 between	WT	
and	KI	cardiomyocytes.	AngII	increased	Ca2+	spark	frequency	from	1.50±0.34	to	
2.13±0.52	1/100	µm-1s-1	(P=0.22)	in	WT,	and	from	1.33±0.13	to	1.83±0.48	1/100	






Electrocardiogram	 (ECG)	 and	 programmed	 electrical	 stimulations	 were	 per-
formed	 on	 chronically	 AngII	 infused	 WT	 and	 KI	 mice,	 to	 test	 whether	 AngII-









Figure	 3.19.	 Chronic	 infusion	 of	 AngII	 to	 WT	 and	 KI	 mice	 do	 not	 induce	 arrhythmia.	
Original	ECG	traces	showed	similar	ECG	parameters	in	WT	and	KI	mice	after	two	weeks	of	AngII	
exposure	(A,	left).	Moreover,	in	vivo	programmed	electrical	burst	stimulation	could	not	induce	a	


























Baseline ECG ECG upon burst stimulation Baseline ECG ECG upon burst stimulation












of	 redox-active	 PKA	 in	 heart	 failure	 conditions,	 I	 have	 used	 transverse	 aortic	
constriction	model	(TAC)	in	redox-dead	PKA	mice	as	well	as	their	WT	litterma-
tes.	In	this	procedure	constriction	of	aorta	increases	afterload-mediated	ventric-





In	 order	 to	 test,	 if	 chronic	 pressure	 overload	 by	 transverse	 aortic	 constriction	
may	result	in	increased	generation	of	reactive	oxygen	species,	isolated	ventricu-
lar	cardiomyocytes	from	TAC-operated	mice	were	investigated	in	the	presence	of	
CellROX.	Upon	6	weeks	 of	 TAC,	 isolated	 cardiomyocytes	 from	both	KI	 and	WT	
mice	 showed	 increased	 CellROX	 fluorescence.	 Similar	 to	 the	 data	 obtained	 in	
mice	having	CTRL	OMP,	 sham-surgery	did	not	affect	ROS	production	 (fig.3.20).	
CellROX	fluorescence	changed	only	minimally	in	WT	and	KI	cardiomyocytes	after	
sham	surgery	 (fig.3.20).	 In	 contrast,	 after	TAC,	 there	was	a	 time-dependent	 in-
crease	 in	CellROX	 fluorescence	 in	both	WT	and	KI	cardiomyocytes,	which	 is	an	




RR	Interval	(s) 0.122 ±0.0147 0.125 ±0.0175 0.132 ±0.0077 0.114 ±0.0016
Heart	Rate	(BPM) 499.100 ±60.3001 488.700 ±68.3000 456.733 ±28.2006 525.850 ±7.1499
PR	Interval	(s) 0.041 ±0.0049 0.034 ±0.0001 0.038 ±0.0032 0.033 ±0.0004
P	Duration	(s) 0.010 ±0.0011 0.010 ±0.0008 0.008 ±0.0008 0.009 ±0.0014
QRS	Interval	(s) 0.011 ±0.0039 0.009 ±0.0003 0.010 ±0.0015 0.009 ±0.0001
QT	Interval	(s) 0.019 ±0.0024 0.025 ±0.0003 0.020 ±0.0022 0.018 ±0.0010
QTc	(s) 0.055 ±0.00347 0.069 ±0.0057 0.055 ±0.0079 0.053 ±0.0033
JT	Interval	(s) 0.008 ±0.0015 0.016 ±0.0001 0.009 ±0.0008 0.009 ±0.0009
Tpeak	Tend	Interval	(s) 0.006 ±0.001848 0.013 ±0.0008 0.007 ±0.0004 0.007 ±0.0008
P	Amplitude	(mV) 0.114 ±0.0398 0.163 ±0.0350 0.139 ±0.0068 0.189 ±0.0311
Q	Amplitude	(mV) -0.063 ±0.0277 -0.033 ±0.0084 0.000 ±0.0088 -0.021 ±0.0181
R	Amplitude	(mV) 1.003 ±0.1748 1.103 ±0.1020 1.097 ±0.2003 0.942 ±0.1657
S	Amplitude	(mV) -0.349 ±0.0303 -0.298 ±0.1295 -0.393 ±0.0523 -0.495 ±0.1518









difference	 in	 CellROX	 fluorescence	 between	 WT	 and	 KI	 cardiomyocytes	 were	
found	after	TAC.	
		
Figure	 3.20.	 Pressure	 overload	 induces	 ROS	 production	 in	 cardiomyocytes.	 Original	
recordings	 (A,	 left)	 and	 quantitative	 data	 represented	 as	 mean±standard	 error	 (B,	 right).		
Isolated	ventricular	 cardiomyocytes	 from	TAC-	or	 sham-operated	WT	and	KI	mice	 loaded	with	
cytosolic	ROS	indicator	CellROX,	were	monitored	for	14	minutes	(A).	For	improved	visualization,	
grayscale	values	were	converted	to	color	using	the	depicted	calibration	bar	(A).	Both	WT	and	KI	
cardiomyocytes	 produced	 oxidants	 after	 TAC	 operation.	 At	 7	min,	 CellROX	 fluorescence	 (F/F0)	
intensity,	were	increased	significantly	in	WT	cardiomyocytes	and	also	showed	a	similar	tendency	








ratio	 increased	significantly	 in	WT	mice	after	TAC	 (Sham	vs.	TAC,	0.319±0.134	
vs.	 1.156±0.413).	 In	 sharp	 contrast,	 similar	 to	 data	 obtained	 upon	AngII	 expo-
sure,	 TAC	 could	 not	 increase	 PKA	 RI	 oxidation	 in	 KI	mice	 (fig.3.21)	 (Sham	 vs.	
TAC,	0.02±0.01	vs.	0.14±0.04).		
	
In	order	 to	 test,	 if	 increased	oxidized	PKA	upon	TAC	would	result	 in	 increased	
phosphorylation	 of	 LTCC,	 PKA-dependent	 phosphorylation	 was	 analyzed	 by	
western	 blotting.	 Figure	 3.22	 shows	 that	 TAC	 surgery	 led	 to	 increasing	 in	 α1c	
phosphorylation	at	serine	1928	in	WT	mice		(p-LTCC/LTCC	levels	were	Sham	vs.	
TAC,	1.28±0.04	vs.	3.21±0.68,	P<0.05,	fig.3.22).	In	accordance	with	abolished	ox-










1.3 WT TAC, N=8 WT Sham, N=4




























in	 accordance	 with	 previously	 published	 data	 (see	 discussion).	 	 In	 WT	 mice,	




Figure	 3.21.	 Pressure	 overload	 increases	 PKA	 RI	 dimer	 only	 in	WT	 but	 not	 in	 KI	 mice.	
Oxidized	 type	 I	 PKA	 causes	 subsequent	 intermolecular	 RI	 dimer	 formation	 (A).	 Upon	 TAC	
operation,	increased	oxidants	could	modify	more	PKA	RI	subunits	to	form	dimer	compared	to	KI	
(B).	 However,	 the	 catalytic	 subunit	 of	 PKA	 got	 reduced	 upon	 TAC	 (C).	 Quantitative	 data	
represented	 as	 mean±standard	 error.	 At	 least	 three	 independent	 mice	 were	 used	 per	 group,	
ANOVA	was	used	for	statistics;	*	means	P<0.05.	
	
The	 effects	 of	 TAC	 on	 expression	 and	 posttranslational	 modifications	 of	 other	
essential	 Ca2+	 regulatory	 proteins	 were	 also	 investigated	 by	 western	 blotting	
(fig.3.22).	 Interestingly,	 TAC	 resulted	 in	 an	 increased	 PLB	 phosphorylation	 at	





was	unchanged,	 SERCA2a/PLB	 ratio	was	 increased	 in	WT	 (fig.3.22)	 suggesting	
that	SERCA2a	activity	may	be	increased.	Compared	to	control,	SERCA2a/PLB	ra-
tio	increased	in	WT	from	0.21±0.02	to	0.42±0.02	(P<0.05,	fig.3.21).	In	contrast,	in	
KI	 mice	 SERCA2a/PLB	 levels	 were	 already	 increased	 under	 sham	 condition		
(P=0.06,	 fig.3.22)	 and	 did	 not	 increase	 further	 upon	 TAC.	 In	 KI	 mice,	



























































































Surprisingly,	 while	 RyR2	 expression	 was	 unchanged	 after	 TAC	 in	 WT,	 it	 de-
creased	 significantly	 in	 KI	 mice	 (fig.3.22).	 RyR2	 levels	 were	 1.26±0.16	 vs.	




















































































































































































































































































the	 other	 hand,	 similar	 to	 SERCA2a/PLB	 expression	 ratio,	 RyR2	 serine	 2808	
phosphorylation	was	 increased	 in	KI	 already	under	 control	 conditions	 and	did	




2.28±0.15	 vs.	 1.93±0.09,	 Sham	vs.	 TAC,	 P=0.07,	 and	 in	KI	mice	 the	 levels	were	
2.12±0.06	vs.	1.7±0.13	(P=0.07,	fig.3.21).		
	
Figure	 3.23.	 CaMKII	 and	 PKC	 expressions	 are	 not	 different	 in	 mice	 upon	 pressure	
overload.	 After	 six	 weeks	 of	 TAC,	 expression	 of	 CaMKII	 was	 increased;	 however,	 PKC	 level	
stayed	same	(A).	However,	autophosphorylation	of	CaMKII	was	also	increased	in	both	WT	and	KI	
TAC	 groups	 (B).	 Quantitative	 data	 represented	 as	 mean±standard	 error.	 At	 least	 three	
independent	mice	were	used	per	group,	ANOVA	was	used	for	statistics;	*	means	P<0.05.	
	





CaMKII	 levels	 from	 1.16±0.15	 to	 1.85±0.27	 (P<0.05,	 fig.3.23)	 and	 p-
CaMKII/CaMKII	 from	 0.35±0.08	 to	 0.94±0.09,	 Sham	 vs.	 TAC,	 P<0.05.	 This	 in-
crease	 was	 also	 observed	 in	 KI	 mice.	 TAC	 increased	 CaMKII	 levels	 from	
1.19±0.11	to	1.81±0.15	(P=0.11,	fig.3.23)	and	p-CaMKII/CaMKII	from	0.58±0.14	
vs.	 0.99±0.14,	 Sham	 vs.	 TAC	 (P<0.05,	 fig.3.23)	 in	 KI,	 although	 the	 increase	 in	































































































































tion	 in	 cardiac	 function	 compared	 to	 control	 and	WT	mice.	KI	 also	 had	more	 severe	dilatation	
compared	to	other	groups	as	revealed	by	systolic	left	ventricular	inner	diameter	(B,	middle	and	
lower	panel).	This	contractile	dysfunction	might	responsible	for	significantly	higher	mortality	in	
KI	 compared	 to	WT	 upon	 TAC	 (C).	 Quantitative	 data	 represented	 as	mean±standard	 error.	 At	
least	 three	 independent	 mice	 were	 used	 per	 group,	 ANOVA	 was	 used	 for	 statistics;	 *	 means	
P<0.05.	
WT Sham KI Sham 











p=0.0148 (log rank test)
WT TAC, N=29
KI TAC, N=25

















































































































































































impairment	of	 contractile	 function	 compared	 to	 sham-operated	mice	 (fig.3.24).	
Both	ejection	fraction	and	fractional	area	shortening	were	significantly	reduced.	
EF	 was	 46.22±5.44	 vs.	 36.11±2.37,	 Sham	 vs.	 TAC,	 P<0.05;	 and	 FAS	 was	
38.39±5.76	 vs.	 29.60±1.87,	 Sham	vs.	 TAC,	 P<0.05.	This	TAC-dependent	 impair-
ment	 of	 contractile	 function,	 however,	 was	 significantly	 more	 severe	 in	 mice	
lacking	 the	 oxidative	 activation	 of	 PKA	 (KI,	 fig.3.24).	 TAC	 decreased	 EF	 to	
21.62±1.27	vs.	43.64±0.99	(Sham,	P<0.05)	in	KI	mice	and	this	reduction	was	sig-
nificantly	more	pronounced	compared	 to	WT	TAC	(P<0.05).	Similarly,	FAS	was	
significantly	more	 reduced	 in	KI	upon	TAC	 to	15.77±1.22	 (P<0.05	vs.	WT	TAC,	
fig.3.24).	 Importantly,	 lack	 of	 redox-dependent	 PKA	 activation	 increased	 the	




Figure	3.25.	Pressure	overload	 induces	morphologic	changes	 in	 the	heart.	Representative	
MTC	 and	Hematoxylin	 staining	 of	whole	 heart	 sections	 showed	 that	KI	 had	more	 hypertrophy	
than	WT	upon	six	weeks	of	TAC	 (A,	 left).	Heart	weight	 to	body	weight	or	heart	weight	 to	 tibia	
length	ratio	also	 indicated	a	similar	pattern	(B).	 Immunohistochemical	analysis	showed	that	KI	



















































































































the	 regulation	 of	 left	 ventricular	 hypertrophy	 upon	 increased	 afterload.	 Com-
pared	 to	 sham,	 TAC	 increased	 wall	 thickness	 to	 0.89±0.03	 mm	 (vs.	 Sham	
0.69±0.01	 mm,	 P<0.05)	 in	 WT,	 and	 to	 0.94±0.03	 mm	 	 (Sham	 0.65±0.09	 mm,	
P<0.05)	in	KI	(P=N.S.	vs.	WT	TAC,	fig.3.24).	Besides,	immunohistochemical	analy-
sis	showed	that	KI	mice	have	a	tendency	to	have	more	fibrosis	compared	to	WT	












HR	(bpm) 471.333 ±17.372 466.063 ±15.193 433.000 ±20.000 486.857 ±5.969
BW	(g) 26.800 ±2.312 23.825 ±0.833 24.150 ±3.150 22.521 ±0.956
FS	(%) 21.061 ±2.123 16.055 ±1.425 20.204 ±0.723 6.860 ±0.846
SV	(µl) 41.755 ±3.449 37.759 ±2.106 34.544 ±4.366 30.553 ±1.675
CO	(ml/min) 19.799 ±2.321 17.796 ±1.360 14.870 ±1.199 14.888 ±0.857
CI	(µl/min/g) 734.812 ±29.460 759.974 ±66.419 619.811 ±31.174 663.146 ±30.723
LVIDd	(mm) 4.581 ±0.169 4.628 ±0.120 4.304 ±0.140 5.007 ±0.102
Vol	s	(µl) 49.731 ±7.733 70.712 ±6.832 44.428 ±3.843 114.266 ±7.616
Vol	d	(µl) 91.486 ±6.458 108.470 ±7.125 78.972 ±8.209 144.819 ±8.136
PWThd	(mm) 0.609 ±0.032 0.752 ±0.044 0.540 ±0.048 0.722 ±0.031
AWThs	(mm) 0.946 ±0.167 1.161 ±0.048 0.913 ±0.058 1.088 ±0.044
PWThs	(mm) 0.748 ±0.026 0.886 ±0.055 0.662 ±0.076 0.802 ±0.030
Ls	(mm) 7.140 ±0.187 7.658 ±0.202 7.059 ±0.151 8.938 ±0.183
Ld	(mm) 8.190 ±0.124 8.461 ±0.153 7.754 ±0.304 9.607 ±0.191
3 16 2 14







surgery.	 Original	 whole	 cell	 patch	 clamp	 traces	 of	 WT	 and	 KI	 isolated	 ventricular	
cardiomyocytes	upon	six	weeks	of	TAC	(A).	Even	though	KI	had	a	large	cell	compared	to	WT,	as	
expressed	by	high	capacitance,	the	current	density	was	lower	in	KI	(A).	Graphical	representation	
of	 current-voltage	 protocol	 used	 in	 this	 experiment	 (A,	 right).	 Upon	 six	 weeks	 of	 TAC,	 WT	
maintained	 ICa	but	KI	 could	not	 (B).	Compared	 to	WT	and	control,	KI	had	significantly	 reduced	
peak	current	at	0	mV	(C).	Moreover,	capacitance	analysis	showed	that	KI	had	high	capacitance,	
meaning	bigger	cells	than	WT	mice	(D).	Quantitative	data	represented	as	mean±standard	error.	
At	 least	 two	 independent	mice	were	 used	 per	 group,	 ANOVA	was	 used	 for	 statistics;	 *	means	
P<0.05.	
	
At	 0	 mV,	 peak	 ICa	 was	 -5.77±0.24	 vs.	 -5.60±0.23	 A/F	 (Sham	 vs.	 TAC,	 P=N.S.,	
fig.3.26).		In	sharp	contrast,	TAC	significantly	reduced	peak	ICa	in	cardiomyocytes	
lacking	oxidative	activation	of	PKA	(fig.3.24).	In	KI	mice,	peak	ICa	was	significant-

















































































that	 redox	PKA	 is	 crucial	under	stress	but	not	 in	normal	conditions.	Moreover,	





In	 order	 to	 test,	 if	 Ca2+	 channel	 dysregulation	 indeed	 underlies	 the	 contractile	
dysfunction	 observed	 in	 KI	mice,	 calcium	 transients	were	measured	 in	 cardio-
myocytes	 isolated	 from	TAC-operated	mice.	There	was	 a	 strong	 trend	 towards	
reduced	 Ca2+	 transient	 amplitude	 in	 ventricular	 cardiomyocytes	 isolated	 from	
mice	six	weeks	after	TAC	(fig.3.27).	At	0.5	Hz	stimulation,	Ca2+	transient	ampli-
tude	decreased	in	WT	to	0.15±0.01	(Sham	0.21±0.02,	P<0.05,	 fig.3.27).	Surpris-
ingly,	 although	 there	 was	 a	 trend,	 there	 was	 no	 significant	 difference	 in	 Ca2+	
transient	amplitude	between	WT	and	KI	cardiomyocytes	after	TAC.	 In	KI	cardi-




activity.	 In	WT	cardiomyocytes,	 the	 time	constant	of	decay,	 tau,	 increased	with	
TAC	from	0.39±0.03	(Sham)	to	0.51±0.04	s	(P=0.24,	 fig.3.27).	Similarly,	TAC	in-





















Figure	 3.27.	 Pressure	 overload	 impairs	 calcium	 handling	 of	 isolated	 cardiomyocytes.	
Original	traces	and	quantitative	analysis	of	Ca2+	transients	(A,	top).	Representative	transients	at	
0.5	Hz	showed	that	both	WT	and	KI	had	reduced	Ca2+	transient	amplitude	and	delayed	reuptake	
of	 Ca2+	 to	 the	 SR	upon	 six	weeks	 of	 TAC	 (A,	 bottom).	Quantitative	mean	data	 showed	 that	 the	
reduction	in	Ca2+	transient	amplitude	was	more	pronounced	in	KI	compared	to	WT	and	control	
groups.	 In	 addition,	 reuptake	 of	 Ca2+	 back	 to	 SR	was	much	 slower	 in	 KI	 compared	 to	WT	 (A,	
below).	 This	 was	 further	 reflected	 from	 the	 caffeine-induced	 Ca2+	 transient	 data,	 where	 KI	






In	order	to	test,	 if	 the	more	severely	 impaired	 left	ventricular	remodeling	of	KI	



































































































































































































































Figure	 3.28.	 Pressure	 overload	 increases	 the	 arrhythmogenic	 vulnerability	 in	 KI	 mice.	
Original	 ECG	 traces	 during	 programmed	 electrical	 stimulation	 in	 vivo	 showed	 altered	 ECG	
parameters	in	KI	after	six	weeks	of	TAC	compared	to	WT	(A,	left).	Interestingly,	in	TAC-operated	
WT	mice,	burst	stimulation	did	not	induce	arrhythmias	(A,	right).	In	contrast,	in	TAC-operated	KI	
mice,	 the	 same	 protocol	 induced	 polymorphic	 VT.	 Colum	 graph	 showed	 numbers	 of	 mice	





Mean	 data	 showed	 that	 TAC	 increased	 QTc	 in	 both	 WT	 (Sham	 vs.	 TAC,	
54.10±4.84	vs.	63.33±4.18	ms,	P=0.52)	and	KI	mice	 (Sham	vs.	TAC,	53.83±2.92	
vs.	97.57±10.29	ms,	P<0.05,	 fig.3.28).	However,	 the	 increase	in	QTc	was	signifi-
cantly	more	pronounced	in	KI	mice	(P<0.05	vs.	WT,	fig.3.28).	A	similar	tendency	
was	 observed	 for	 the	 T	 peak-Tend	 interval,	 which	was	 increased	 after	 TAC	 in	





































Baseline ECG ECG upon burst stimulationBaseline ECGECG upon burst stimulation
















































































Figure	 3.29.	 Oxidation	 of	 PKA	 regulatory	 subunit	 at	 different	 disease	 stages.	 	 Original	








patients	with	 permanent	 atrial	 fibrillation	 or	 sleep-disordered	 breathing,	 indi-






RR	Interval	(s) 0.116 ±0.0049 0.137 ±0.0107 0.127 ±0.0054 0.122 ±0.0033
Heart	Rate	(BPM) 521.167 ±21.6738 447.525 ±33.3085 476.800 ±20.4684 495.814 ±13.4287
PR	Interval	(s) 0.037 ±0.0015 0.041 ±0.0015 0.037 ±0.0024 0.035 ±0.0014
P	Duration	(s) 0.008 ±0.0011 0.008 ±0.0011 0.008 ±0.0007 0.008 ±0.0006
QRS	Interval	(s) 0.007 ±0.0005 0.010 ±0.0003 0.009 ±0.0008 0.012 ±0.0019
QT	Interval	(s) 0.018 ±0.0013 0.023 ±0.0017 0.019 ±0.0008 0.034 ±0.0033
JT	Interval	(s) 0.011 ±0.0017 0.014 ±0.0019 0.010 ±0.0011 0.022 ±0.0018
P	Amplitude	(mV) 0.140 ±0.0272 0.138 ±0.0049 0.103 ±0.0169 0.137 ±0.0161
Q	Amplitude	(mV) -0.026 ±0.0115 -0.035 ±0.0085 -0.014 ±0.0097 -0.011 ±0.0058
R	Amplitude	(mV) 0.850 ±0.1297 0.889 ±0.0364 0.889 ±0.115 1.324 ±0.3049
S	Amplitude	(mV) -0.258 ±0.0968 -0.105 ±0.0743 -0.335 ±0.0594 -0.167 ±0.0668









































































effects.	 However,	 the	 relevance	 of	 this	 pathway	 for	 the	 cardiac	 function	 was	
completely	 unknown.	 Thus,	 a	 novel	 mouse	 line	 has	 been	 used	 in	 this	 study,	
which	has	only	a	single	amino-acid	substitution	compared	to	its	WT	littermates.	
This	point	mutation	changes	cysteine	at	position	17	to	serine.	This	alteration	has	
no	 effect	 on	 protein	 structure,	 conformation	 or	 conventional	 agonist	 (cAMP)	
binding	for	downstream	signaling	(Brennan	et	al.,	2006;	Burgoyne	et	al.,	2015).	

















with	 increased	 ICa	 partially	 compensate	 Ca2+	 transients.	 Interestingly,	 results	
from	 this	 study	 show	 that	 at	 baseline	 KI	 cardiomyocytes	maintained	 a	 higher	
level	of	intracellular	cAMP	compared	to	WT	cardiomyocytes,	implicating	the	role	
of	oxidized	PKA	in	baseline	Ca2+	handling.	Bryant	et	al.	reported	the	role	of	PKA	
also	 in	maintaining	 ICa	 (Bryant	et	al.,	2014).	 	However,	higher	cAMP	concentra-
tions	 in	KI	PKA	correlates	with	baseline	LTCC	phosphorylation,	where	KI	mice	
showed	more	phosphorylation	compared	to	WT	animals.	So,	KI	animals	maintain	
a	higher	 level	of	 cAMP,	which	may	compensate	 its	 inability	 to	activate	PKA	via	
oxidation.	All	 these	data	 strengthen	 the	 idea	 that	at	physiologic	 condition	both	









Stress	 conditions	 induce	 oxidant	 production	 in	 the	 cardiomyocytes.	 However,	
under	chronic	stress	situation,	an	excess	oxidant	may	cause	structural	and	elec-
trical	 remodeling	of	 the	heart,	 contributing	 to	cardiomyopathy,	 fibrillation,	and	
arrhythmia	(Youn	et	al.,	2013).		It	has	been	reported	that	level	of	AngII	is	getting	
higher	under	 stress	 conditions	 (Bers,	 2001).	 Thus,	AngII	 has	been	used	 in	 this	
study	to	mimic	stressed	conditions	to	the	cell	and	also	to	the	whole	heart.	Upon	
acute	exposure,	AngII	induces	a	significantly	higher	amount	of	oxidant	(ROS)	un-






in	 acute	 settings,	 as	 revealed	 by	 MitoSOX,	 a	 superoxide	 detector.	 This	 result	







sure.	Thus,	 it	may	 implicate	that	cytosolic	ROS	is	responsible	 for	mitochondrial	
ROS	production	and	vice	versa.	Brandes	et	al.	and	Zorov	et	al.	termed	this	type	of	
phenomenon	as	ROS-induced	ROS	release	(RIRR)	event	(Brandes,	2005;	Zorov	et	
al.,	 2000).	 They	 found	 that	 upon	 stimulation,	 mitochondrial	 ROS	 could	 induce	
cytosolic	ROS	production	and	vice	versa.	Wen	et	al.	 summarized	three	possible	
mechanisms	 for	RIRR:	 (1)	ROS-mediated	mitochondrial	depolarization	via	acti-









ROS	 production	 to	 this	 increased	 mitochondrial	 oxidants	 production.	 Experi-
ments	 with	 CellROX	 show	 similar	 results,	 where	 AngII	 induced	 significantly	
higher	oxidant	production	upon	acute	exposure.	In	a	similar	study,	Wagner	et	al.	
presented	 AngII-mediated	 cytosolic	 ROS	 production	 using	 an	 adenoviral	 con-
struct	 (Wagner	 et	 al.,	 2014).	 Many	 reports	 indicated	 NOX,	 with	 its	 different	
isoforms,	as	a	primary	source	of	this	cytosolic	oxidant	production	(Brandes	and	




are	 sufficient	 to	produce	enough	 cytosolic	 oxidants.	Hence,	 it	may	well	 be	 that	
both	NOX2	and	4	along	with	the	mitochondrial	electron	transport	chain	are	 in-
volved	 in	 AngII-mediated	 oxidant	 production	 (Brandes	 and	 Kreuzer,	 2005;	
Rajagopalan	et	al.,	1996;	Xiao	et	al.,	2002).	
	
In	vivo	 implantation	 of	 osmotic	minipumps	 containing	AngII	 show	 comparable	
results	 as	 found	 in	 ex	vivo	 condition.	 Infusions	 of	 AngII	 (1mg/kg/day)	 for	 two	
weeks	 increase	 blood	 pressure	 significantly	 in	 both	 WT	 and	 KI	 mice.	 Results	
show	that	upon	in	vivo	AngII	infusion	both	WT	and	KI	animals	produced	signifi-
cantly	higher	oxidant	compared	to	baseline.	Similar	to	these	findings,	it	has	been	
reported	 that	 AngII-mediated	 increase	 in	 systolic	 blood	 pressure	 and	 up-
regulation	of	vascular	ROS	production,	can	be	blocked	by	 losartan,	an	AngII	re-









Moreover,	 transverse	 aortic	 constriction	 (TAC)	 can	 also	 increase	 cytosolic	 oxi-
dant	 production	 as	 visualized	 by	 CellROX.	 After	 six	weeks	 of	 TAC,	 cardiomyo-
cytes	 from	 both	WT	 and	 KI	 animals	 produced	 a	 high	 amount	 of	 oxidant	 com-
pared	 to	baseline	and	sham-operated	mice,	which	correlate	well	with	previous	
reports	 (Schwarzer	 et	 al.,	 2014).	 Thus,	 although	 the	 role	 of	 PKA	 in	 controlling	
cellular	ROS	has	been	reported	previously,	the	results	listed	above	indicate	that	







type	 I	 regulatory	 subunits.	 Isolated	 cardiomyocytes	 expose	 to	 H2O2,	 show	 in-
creased	number	of	RI	 dimers	 compared	 to	 control,	which	demonstrates	 oxida-
tion	of	 type	 I	PKA.	A	 similar	pattern	of	dimer	 formation	 is	 also	observed	upon	
perfusion	of	AngII	to	whole	mice	hearts.	AngII	induces	significantly	higher	dimer	
formation	in	WT	mice	compared	to	control.	As	expected,	KI	mice	cannot	produce	
this	dimer	because	of	 its	absence	of	C17	residue.	These	results	 indicate	 that	KI	





compared	 to	 their	 control	 littermates.	Burgoyne	 et	 al.	 reported	 similar	 results,	
where	VEGF-induced	oxidant	can	mediate	dimer	formation	only	in	WT	but	not	in	




















cytes	are	gone	with	H89,	 showing	PKA	 is	 involved	here.	 Interestingly,	baseline	
increase	in	the	cAMP	level	of	KI	is	diminished	upon	AngII,	supporting	the	inabil-
ity	 of	KI	 to	maintain	 even	 the	baseline	 ICa	 level.	However,	 both	 the	WT	and	KI	
cardiomyocytes	have	reduced	SR	Ca2+	content	upon	acute	and	chronic	AngII	ex-




myocytes	 have	 similar	 spark	 frequency	 upon	 AngII,	 indicating	 that	 RyR2	 does	
not	play	a	prominent	role	in	these	settings.	This	result	is	in	agreement	with	our	
previous	report	showing	the	involvement	of	CaMKII	in	spark	regulation	(Wagner	
et	 al.,	 2014).	Western	 blot	 analyses	 also	 showed	 that	WT	mice	 could	 increase	
stress-induced	LTCC	phosphorylation	but	KI	animals	could	not.	 Involvement	of	
PKA	 type	 I	 in	LTCC	regulation	was	documented	 long	ago	by	Burton	et	 al.,	who	
showed	that	type	I	could	attach	and	modulate	LTCC	even	in	the	absence	of	type	II	
PKA	(Burton	et	al.,	1997).	Although	reports	have	been	shown	that	LTCC	can	be	
phosphorylated	by	 both	PKA	 and	PKC	 at	 S1928	position	 (Aiello	 and	Cingolani,	
2001),	Ichiyanagi	et	al.	showed	a	PKC-independent	increase	in	ICa	upon	AngII	via	
AT1	 receptor	 (Ichiyanagi	 et	 al.,	 2002).	 Our	 data	 indicated	 that	 this	 PKC-
independent	 increase	 might	 be	 mediated	 by	 oxidized	 PKA.	 Bers	 and	 his	 col-
leagues	mentioned	that	upon	phosphorylation	the	open	probability	of	pore	form-
ing	 α1c	 subunit	gets	 higher	 as	 well	 as	 the	 activation	 potential	 shifted	 towards	
more	negative	membrane	potentials	(Bers,	2001).	Thus,	at	a	certain	time,	more	







compared	 to	 control	 and	KI	mice	upon	AngII	 treatment,	meaning	 that	 the	Ca2+	
transient	 decay	 is	 faster	 in	WT	 compared	 to	 KI	mice.	 However,	 this	 is	 not	 the	
















to	 maintain	 the	 transients.	 The	 inability	 of	 KI	 animals	 to	 phosphorylate	 LTCC	









All	 these	 in	 vitro	 Ca2+	 handling	 impairments	 suggest	 that	 KI	 mice	 could	 have	
compromised	 cardiac	 function	 upon	 stress	 compared	 to	 WT	 mice.	 Data	 from	
other	groups	showed	that	AngII	can	mediate	several	effects	via	directly	modify-
ing	 cardiomyocytes	 or,	 indirectly,	 increasing	 blood	 pressure	 (Mazzolai	 et	 al.,	
2000).	AngII	significantly	increases	blood	pressure	in	both	WT	and	KI	mice	and	
induces	 similar	morphological	 changes	as	visualized	by	MTC	and	H/E	 staining.	
Echocardiography	 shows	KI	 animals	have	much	 compromised	 cardiac	 function	
compared	to	WT	upon	AngII	exposure.	While	WT	mice	could	maintain	similar	EF,	




fusion	WT	mice	 had	 only	 a	mild	 increase	 in	 FS	 compared	 to	 control,	 which	 is	
comparable	to	our	study	(Dai	et	al.,	2011b).	However,	EF	and	FAS	are	more	re-
duced	 in	KI	 animals	 compared	 to	WT	mice,	 although,	 not	 significant.	 A	 similar	
trend	is	also	observed	in	cardiac	output	and	cardiac	index,	which	are	much	lower	
in	KI	mice	compared	to	WT	animals.	However,	both	WT	and	KI	animals	have	sim-
ilar	 dilatation	 upon	 AngII;	 whereas	WT	 have	more	 hypertrophy	 than	 KI	mice.	
The	ratio	of	heart	weight	and	body	weight	also	show	that	WT	mice	had	more	hy-
pertrophy	than	KI	animals	upon	chronic	AngII	 infusion.	This	AngII-induced	hy-







pertrophy.	 KI	 mice,	 which	 cannot	 oxidize	 PKA	 upon	 these	 increased	 oxidants,	





length	 ratio.	 Reports	 have	 been	 shown	 that	 several	 components	 of	 the	 renin-




ed	by	 feeding	 the	animal	with	ACE	 inhibitor	Enalapril	maleate	using	rat	 in	vivo	
model	 (Baker	 et	 al.,	 1990).	Other	 reports	 also	 showed	 that	not	 only	 the	 renin-
angiotensin	 system	 but	 also	 multiple	 pathways,	 for	 example,	 CaMKII,	 MAPK,	
HDAC	are	additionally	 involved	 in	 the	pressure	overload-induced	hypertrophic	
process.	 This	 perception	 is	 in	 agreement	 with	 the	 reports,	 which	 have	 shown	
that	 abdominal	 aortic	 constriction	 in	 AT1A	 receptor	 knockout	 mice	 produced	
cardiac	 hypertrophy	 independent	 of	 the	 AT1	 receptor	 (Hamawaki	 et	 al.,	 1998;	
Discussion	
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Goonasekara	 et	 al.	 also	 demonstrated	 that	 reduced	 LTCC	 activity	 is	 associated	
with	 cardiac	 hypertrophy,	 which	 is	 mediated	 by	 neurohormonal	 stress	 and	




ing	 to	 maintain	 sufficient	 cardiac	 contractions,	 but	 ultimately	 fail.	 These	 data	






































beat	 caused	 by	 disturbed	 electrophysiology	 of	 the	 myocardium	 (Youn	 et	 al.,	





reported	 for	 these	 drugs	 (Sanguinetti	 and	 Bennett,	 2003).	 In	 addition	 to	 β-
receptor	 dysregulation,	 both	 loss	 and	 gain	 of	 function	mutations	 of	 LTCC	have	
been	 reported	 to	 be	 involved	 in	 ventricular	 arrhythmia	 (Burashnikov	 et	 al.,	
2010;	Splawski	et	al.,	2005).	As	 found	 in	 this	study,	decreased	 ICa	current	 in	KI	
mice,	 upon	 AngII	 and	 pressure	 overload-induced	 stress,	 may	 also	 be	 pro-
arrhythmogenic.	This	finding	is	further	supported	by	Koncz	et	al.	who	reported	









the	 CaMKII	 inhibitor	 KN-93	 attenuated	 the	 occurrence	 of	 AngII-induced	 EADs	
(Xie	 et	 al.,	 2009;	 Zhao	 et	 al.,	 2011).	 Pereira	 et	 al.	 showed	 that	 β1-AR	 activates	
Epac2	 to	 induce	SR	Ca2+	 leak	via	CaMKIIδ-dependent	phosphorylation	of	RyR2-











KI	 mice	 have	 more	 propensity	 to	 arrhythmia	 after	 TAC	 than	 WT	 and	 sham-
operated	mice.	Moreover,	expression	of	the	catalytic	subunit	of	PKA,	which	was	
decreased	upon	pressure	overload	and	mildly	decreased	upon	AngII,	additionally	
supports	 the	 idea	 that	 reduced	 PKA	 activity	 is	 associated	 with	 increased	 ar-









to	 volume	 or	 pressure	 overload.	 It	 involves,	 for	 example,	 cardiomyocyte	 en-
largement,	cardiac	fibroblast	proliferation	and	collagen	formation,	extensive	re-
modeling	of	ion	channels,	gap	junctions,	calcium	handling,	and	the	cytoskeleton.	





















sleep	 apnea	 (OSA)	 patients	 show	 analogous	 results,	 where	 permanent	 AF	 and	
severe	 OSA	 patients	 (apnea-hypopnea	 index,	 AHI>10)	 show	 a	 significant	 in-
crease	 in	 PKA	 dimer	 formation	 compared	 to	 their	 sinus	 rhythm	 counterparts.	
Interestingly,	mild	AF	patients	 (paroxysmal	AF)	 or	mild	OSA	 (AHI<10)	 show	a	
comparable	amount	of	dimer	as	like	sinus	rhythm	patients.	It	may	well	be	that	at	
extremely	 diseased	 conditions	 produce	more	 ROS	 to	 initiate	 special	 signaling,	





Although	 oxidative	 stress	 is	 implicated	 as	 a	 causative	 agent	 for	 cardiovascular	
diseases,	most	of	the	large	clinical	trials	of	antioxidant	failed	to	show	any	signifi-
cant	 protection	 against	 cardiovascular	 diseases	 (1999;	 de	 Gaetano	 and	
Discussion	
	 118	




advantage	 to	 patients	 with	 different	 heart	 diseases,	 like	myocardial	 infarction	
(MI),	stroke	or	CVD	associated	death.	Moreover,	few	clinical	studies	even	showed	
severe	adverse	effects	such	as	death	upon	the	antioxidant	 therapy.	As	 found	 in	
ATBC	 (deal	 with	 nonsmokers)	 or	 CARET	 (deal	 with	 Asbestos	 workers)	 study,	
where	 antioxidant	 therapy	 induces	 a	 severe	 hemorrhagic	 stroke	 or	 all-cause	
mortality,	respectively	(1994;	Brown	et	al.,	2001;	Omenn	et	al.,	1996;	Waters	et	













Catecholamine-mediated	 cardiac	 inotropic,	 chronotropic,	 and	 lusitropic	 effects	
are	 mostly	 maintained	 by	 β-AR/PKA-cAMP	 signaling	 pathway.	 Many	 reports	





PKA	 activity	 might	 be	 a	 strategy	 to	 improve	 cardiac	 function	 (Zakhary	 et	 al.,	
1999).	Interestingly,	overexpression	of	either	the	catalytic	subunit	of	PKA	(Antos	





timate	 death	 from	 cardiac	 failure;	 suggesting	 detrimental	 role	 of	 β-AR/PKA-
cAMP	 signaling	 pathway.	 It	 may	 well	 be	 that	 overexpression	 of	 PKA	 catalytic	























Another	point	 is	 that,	 β1	 and	β2	 receptors	maintain	 their	 own	 compartment	 of	
cAMP	in	the	cell	(Di	Benedetto	et	al.,	2008).	LTCC	has	been	reported	to	be	mostly	
located	in	β2	compartments,	which	is	concentrated	on	T-tubules.	Interestingly,	β	






cell	 similar	 to	 adenylyl	 cyclase	 overexpression.	 The	 reason	 is	 that	 both	 these	
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